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INTRODUCTION
Plants have been utilized as medicine for thousands of years. These medicines 
initially took the form of tinctures, teas, powders and other herbal formulations. The 
specific plants to be used and methods of application for particular ailments were 
passed down through oral history. In more recent history, the use of plants as 
medicine has involved the isolation of active compounds, beginning with the isolation 
of morphine from opium in the early 19th century.  Drug discovery from medicinal 
plants led to the isolation of early drugs such as cocaine, codeine, digitoxin and 
quinine in addition to morphine of which some are still in use. Isolation and 
characterization of pharmacologically active compounds from medicinal plants 
continue today. More recently, drug discovery techniques have been applied to the 
standardization of herbal medicines to elucidate analytical marker compounds(1-3).
Importance of medicinal plants in drug discovery
Numerous methods have been utilized to acquire compounds for drug 
discovery including isolation from plants and other natural sources, 
synthetic chemistry an molecular modeling.  Despite the recent interest in 
molecular modeling, combinatorial chemistry and other synthetic 
chemistry technique by pharmaceutical companies and funding 
organizations, natural products and particularly medicinal plants remain 
an important source of new drugs, new drug leads and new chemical 
entities (NCEs).  In both 2001 and 2002, approximately one quarter of 
   
the best selling drugs worldwide were natural products or derived from 
natural products(4-6). 
There are also four new medicinal plant-derived drugs that have been 
recently introduced to the US market.
Fig. 01.  EXAMPLES OF NEW MEDICINAL PLANT DRUGS 
RECENTLY INTRODUCED TO MARKET OR IN LATE-PHASE 
CLINICAL TRIALS.
   
Arteether (1, trade name Artemotil) is a potent anti-malarial drug and is 
derived from artemisinin, a sesquiterpene lactone isolated from Artemisia  
annua L. (Asteraceae), a plant used in traditional Chinese medicine 
(TCM).  Other derivatives of artemisinin are in various stages of use or 
clinical trials as anti-malarial drugs in Europe (7)
   
Galantamine (2, also known as Galanthamine, trade name Remminyl) is a 
natural product discovered through an ethno botanical lead and first 
isolated from Galanthus woronowii Losinsk (Amaryllidaceae) in Russia 
in the early 1950s.  Galantamine is approved for the treatment of 
Alzheimer’s disease, slowing the process of neurological degeneration by 
inhibiting acetyl cholinesterase (AchE) as well as binding to modulating 
the nicotine acetylcholine receptor (nAchR)(8).
Nitisinone (3, trade name Orfadin) is a newly released medicinal plant-
derived drug that works on the rare inherited disease, tyrosinaemia, 
demonstrating the usefulness of natural products as lead structures. 
Nitisinone is a modification of mesotrione; an herbicide based natural 
product leptpspermone, a constituent of Callistemon citrinus Ctapf 
(Myrtaceae).  All three of these triketones inhibit the same enzyme, 4-
hydroxy phenyl pyruvate and dehydrogenase (HPPD), in both human and 
maize. Inhibition of the HPPD enzyme in maize acts as an herbicide and 
results in reduction of plastoquinone and tocopherol biosynthesis, while 
in humans the HPPD enzyme inhibition prevents tyrosine catabolism and 
the accumulation of toxic bioproducts in the liver and kidneys(9).
   
Tiotropium (4, Trade name Spiriva) has recently been released to the 
United States market for the treatment of chronic obstructive pulmonary 
disease (COPD). Tiotropium is an inhaled anticholinergic branchodilator, 
based on ipratropium, a derivative of atropine that has been isolated from 
Atropa belladonna Linn (Solanaceae) and other members of the 
Solanaceae family. Tiotropium has shown increased efficacy and longer 
lasting effects when compared with other available COPD medications 
(10).
Compounds 5 – 7 (Fig. I) are all in Phase III clinical trials or registration 
and are subtle modifications of drugs currently in clinical use (Butler, 
2004). M6G or Morphine — glucuronide (5) is a metabolite of morphine 
from Papaver somniferum Linn (Papaveraceae) and will be used as an 
alternate pain medication with fewer side effects than morphine. 
Vinflunine (6) is a modification of vinblastine from Catharanthus roseus  
Linn G. Don  (Apocynaceae) for use as an anticancer agent with 
improved efficacy (11&12). 
   
Exatecan (7) is an analog of camptothecin from Camptotheca 
accuminata Decne. (Nyssaceae) and is being developed as an anticancer 
agent. Modifications of existing natural products exemplify the 
importance of drug discovery from medicinal plants as NCEs and as 
possible new drug leads(13).
Calanolide A (8) is a dipyranocoumarin natural product isolated from 
Calophyllum lanigerun var. austrocoriaceum (Whitemore) PF Stevens  
(Clusiaceae), a Malaysian raingorest tree. Calanolide A is an anti-HIV 
drug with unique and specific mechanism of action s a non-nuceoside 
reverse transcriptase inhibitor (NNRTI) of type-I HIV and is effective 
against AZT-resistant strains of HIV. Calanolide A is currently 
undergoing Phase II clinical trials (14).
Natural products have played an important role as new chemical entities 
(NCEs)- approximately 28% of NCEs  between 1981 and 2002 were 
natural products or natural product-derived.  Another 20% of NCEs 
during this time period were considered natural product mimics, meaning 
that the synthetic compound was derived from the study of natural 
products. Combining these categories, research on natural products 
accounts for approximately 48% of the NCEs reported from 1981 – 2002. 
   
Natural products provide a  starting point of new synthetic compounds, 
with diverse structures and often with multiple sterocentres that can be 
challenging synthetically.  Many structural features common to  natural 
products (e.g., chiral centers, aromatic rings, complex ring system, 
degree of molecule saturation and number and ratio of hetero atoms) 
have been shown to be highly relevant to drug  discovery efforts (15). 
 Furthermore, since the escalation of interest in combinatorial chemistry 
and the subsequent realization that these compound libraries may not 
always be very diverse, many synthetic and medicinal chemists are 
exploring the creation of natural product and natural product like libraries 
that combine the structural features of natural products with the 
compound-generating potential of combinatorial chemistry.  Drugs 
derived from medicinal plants can serve not only as new drugs 
themselves but also as drug leads suitable for optimization by medicinal 
and synthetic chemists(16-19).
Even when new chemical structures are not found during drug discovery 
from medicinal plants, known compounds with new biological activity 
can provide important drug leads. Since the sequencing of the human 
genome, thousands of new molecular targets have been identified as 
important for various.
   
With the advent of high-throughput screening assays directed towards 
these targets, known compounds from medicinal plants may show 
promising and possibly selective activity.  Several known compounds 
isolated from traditionally used medicinal plants have already been 
shown to act on newly validated molecular targets, as exemplified by 
indirubin, which selectively inhibits cyclin-dependent kinases and 
kamebakaurin, which has been shown to inhibit NF- kB.  Other known 
compounds have also been shown to act on novel molecular targets, thus 
reviving interest in members of these frequently isolated plant compound 
classes.  Three examples are cucurbitacin I, obtained from the National 
Cancer Institute (NCI) Diversity set of known compounds found to be 
highly selective in inhibiting the JAK/STAT 3 pathway in tumors with 
activated STAT 3, β-lapachone, which selectively kills cancer cells over 
normal cells through direct checkpoint activation during the cell cycle 
and betulinic acid, with selective melanoma cytotoxicity through the 
activation of p38(20&21).
Some of the plant derived anticancer agents are under investigation for 
their effect on cancer cells. Some of them are as follows: Betulinic acid 
(9), a pentacyclic triterpene, is a common secondary metabolite of plants, 
primarily from Betula species (Betulaceae).  The Betulinic acid isolated 
   
from the ethyl acetate fraction of  Zisiphus mauritiana Linn 
(Rhamnaceae) was found to have selective cytotoxicity against human 
melanoma cells. Previlleine A (10), along with eight other tropane 
alakaloids was isolated from the roots of Erythroxylum pervillei Bail 
(Erythroxylaceae) was found to be selectively cytotoxic against a multi-
drug resistant (MDR) oral epidermoid cancer cell line (KB-V1) in the 
presence of anticancer agent vinblastine. Silvestrol (11) was first isolated 
from the fruits of Aglaia sylvestris (M Roemer) Merill (Meliaceae) (later 
re identified as Aglaia foveolata Pannel) was found to be cytotoxic 
against several human cancer cell lines (22).
   
Fig. 02.                       PLANT-DERIVED ANTICANCER AGENTS
   
Challenges in drug discovery from medicinal plants (23&24)
Despite the evident successes of drug discovery from medicinal plants, 
future endeavors face many challenges.  Pharmacognosists, 
phytochemists and other natural product scientists will need to 
continuously improve the quality and quantity of compounds that enter 
the drug development phase to keep pace with other drug discovery 
efforts.  The process of drug discovery has been estimated to take an 
average of 10 years upwards  and cost more than 800 million dollars. 
Much of this time and money is spent on the numerous leads that are 
discarded during the drug discovery process. In fact, it has been 
estimated that only one in 5000 lead compounds will successfully 
advance through clinical trials and  be approved for use.  Lead 
identification is the first step in a lengthy drug development process 
(Fig).  Lead optimization (involving medicinal and combinatorial 
chemistry), lead development (including pharmacology, toxicology, 
pharmcokinetics, ADME [absorption, distribution, metabolism and 
excretion] and drug delivery) and clinical trials take a considerable length 
of time.
   
Fig: 03  SCHEMATIC OF TYPICAL PLANT DRUG DISCOVERY 
AND DEVELOPMENT
   
Improving the speed of active compound isolation will  necessitate the 
incorporation  of  new  technologies.   Although  Nuclear  Magenetic 
Resonance (NMR) and Mass Spectrometry (MS) are currently in wide 
use for compound identification, new methods of using NMR and MS 
could be applied to medicinal plant drug discovery to facilitate compound 
isolation.  Also, the use of high-throughput X-ray crystallography could 
be applied to medicinal plant lead discovery.  Compound development of 
drugs  discovered  from medicinal  plants  also  faces  unique  challenges. 
Natural  products  are  typically  isolated  in  small  quantities  that  are 
insufficient  for lead optimization,  lead development  and clinical trials. 
Collaboratibg  with  synthetic  and  medicinal  chemists  is  necessary  to 
determine  if  synthesis  or  semi-synthesiis  might  be  possible.  Another 
technique  to  improve  natural  product  compound  development  may 
involve the creation of natural product and natural-product-like libraries 
that  combine  the  features  of  natural   products  with  combinatorial 
chemistry.
   
In conclusion,  natural  products  discovered from medicinal  plants  (and 
derivatives thereof) have provided numerous clinically used medicines. 
Even with all the challenges facing drug discovery from medicinal plants, 
natural  products  isolated  from  medicinal  plants  can  be  predicted  to 
remain an essential component in the search of new medicines.
REVIEW OF LITERATURE
2. WORKS DONE ON DELONIX REGIA (BOJ. EX HOOK.) RAF.
 R.K.Barua and A.B.Barua(1962) have isolated 3-hydroxy Retinene from 
Anthers of Delonix regia (Boj. ex Hook.) Raf  flowers and also studied 
about the properties of 3-hydroxy retinene.Oxidation of Zeaxanthin with 
hydrogen  peroxide  in  the  presence  of  Osmium  tetroxide  results  in  the 
formation of 3-hydroxy retinene(30).
 Jungalwala F B et.al (1962) studied comparatively the amount and type 
of carotenoids present  in various floral  parts  of  Delonix regia (Boj.  ex 
Hook.) Raf. The highest concentration of total carotenoids were found in 
the anthers of the flower. 90% of its found to be Zeaxanthin(31). 
Zeaxanthin
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 May-Lin-Sung et.al (1968) isolated trans -3-hydroxy Proline from seed of 
Delonix regia (Boj. ex Hook.) Raf and shown to inhibited the growth of 
mung bean seedlings. They also confirmed the presence of  γ-Methylene 
Glutamine in seedlings also(32).
TRANS -3- HYDROXY -L- PROLINE
 L.Fowden  et.al  (1969)  isolated  Azetidine-2-carboxylic  acid  from  the 
leaves of the legume  Delonix regia (Boj. ex Hook.) Raf. The imino acid 
not be detected in dry seeds of the plant but it was produced rapidly during 
germination and it is present in all part of the plants (33).
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 May-Lin-Sung  et.al  (1971)  biosynthesized  Imino  acid  and  studied  in 
Delonix  regia  (Boj.  ex  Hook.)  Raf   seedlings  by  labeled   precursor 
feeding.   α ,γ-Diaminobutyric  acid was incorporated into Azetidine  -2-
carboxylic acid more efficienty than homoserine, methionine or aspartic 
acid.  More  radioactivity  from  proline  was  found  in  trans-3-hydroxy 
proline  after  2  day’s  than  after  4-day’s  metabolism,  indicating  a 
continuous turn over of the hydroxyl imino acid seedlings(34).
S (-) -2- AZETIDINE -2- CARBOXYLIC ACID
 V.P.Kapoor  et.al  (1972)  isolated  a  galactomannan  composed  of  (-) 
galactose and (-) mannose from the seed of Delonix regia (Boj. ex Hook.) 
Raf. It is established that galactomannan is a highly branched 
polysaccharide  consisting  of  the  main  chain  of  mannose  united  linked 
through β(1-4) and side chain of single galactose units linked through α (1-
6) linkage(35).
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 Leslie Fowden et.al  (1973) studied comparatively the thermal  stability 
and  substrate  binding  constants  of  prolyl_t_RNA  synthetase  from 
Phaseolus aureus and Delonix regia  (Boj. ex Hook.) Raf. The results are 
discussed  in  relation  to  the  order  of  substrate  specificity  between  the 
enzymes from Phaseolus aureus and Delonix regia (Boj. ex Hook.) Raf(36).
 Roger  D  Norris  (1973)  isolated  enzyme  Pro-t-RNA  synthetase  from 
Phaseouls  aureus  and  Delonix  regia.  Pro-t-RNA  synthetase  was  photo 
inactivated in the presence of methyelne blue or  Rose Bengal.  Pro and 
several imino acid analogues protected the enzyme against Dye –mediated 
photo inactivation but ATP was ineffective(37).
 D.  Mukherjee  et.al  (1975)  demonstated  Proline  and  hydroxyl  proline 
biosynthesis  from the  floral  parts  and  buds  of  Delonix  regia  (Boj.  ex 
Hook.) Raf. The identified phytoconstituents such as α-ketoglutaric acid, 
oxalo acetic acid , pruvic acid and glyoxylic acid from floral parts and buds. 
They also reported on the calyx and androecium accumalate glyoxlic acid in 
amounts greater than those reported from other plants(38).        
 Roger D Norris et .al (1975) obtained partially purified preparation of 
Phe  and  Tyr  –t-RNA synthetases  from seed  or  seedlings  of  Phaseolus 
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aureus, Further they had demonstrated  Delonix regia (Boj. ex Hook.) Raf 
and Caesalpinia tinctoria ability of a variety of structural analogues of Phe 
or Tyr to act as alternative substrates or inhibitors(39). 
 Nabiel.A.M.et  al  (1976)  reported  Anthocyanins  of  some  leguminosae 
flowers  and their  effect  on  colour  varation  Bauhinia  variegate,  Xassia 
nodosa and  Delonix  regia  (Boj.  ex  Hook.)  Raf.    Flavonoids 
:Anthocyanins were screened in the above plant for its colour variation(40).
 Szymanovicz G et.al (1978) newly synthesized 3-hydroxy proline. That 
is a new method of preparation and some properties of 3-hydroxy proline 
from seed extract of Delonix regia (Boj. ex Hook.) Raf.  The hydrolyzate 
is  fractionated  sequentially  on  Resin  and  sephadex.  Purification  and 
characterization  of  3-hydroxy  proline  clearly  separated  from 4-hydroxy 
proline  was  carried  out  by  means  of  TLC  chromatography  and   high 
voltage paper electrophoresis(41).
 Mendes  NM et.  al  (1986)  screened  Molluscicide  activity  of  aqueous 
(macerated  and  boilrd)  hexanic  and  ethylic  extracts  of  Aristolochia 
brasiliensis,  Ceasalpinia peltophoroides, Delonix regia  (Boj.  ex Hook.) 
Raf. The most active of the extracts studied was  Delonix regia  (Boj. ex 
Hook.) Raf flowers  (flamboyant)  ethylnic  extracts  which  presented 
mollusicidal activity on adult snails at 20ppm(42).
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 Saxena.S.C et.al (1986) evaluated Delonix regia (Boj. ex Hook.) Raf for 
disruptor of insect growth and development. It’s a preliminary laboratory 
evaluation of an extract of leaves of  Delonix regia  (Boj. ex Hook.) Raf 
disruptor of insect growth and development(43).
 Marfo.E.K.  (1989)  evaluated  chemical  and  nutritional  properties  of 
Flamboyant beans (Delonix regia) Delonix regia (Boj. ex Hook.) Raf(44).
 Kpikpi.W.M (1992) RATD  tried Musanga cropioides and Delonix regia 
(Boj. ex Hook.) Raf as papermaking hardwoods(45).
 Channg-Hung Chou (1992) bioassayed a series of aqueous extracts of 
leaves, flowers and twigs of  Delonix regia  (Boj. ex Hook.) Raf against 
three  species  to  determine  their  phytotoxicity  and  the  results  showed 
highest  inhibition  in  the  flowers.  By means  of  TLC,  HPLC and Paper 
chromatography and UV-Visible spectrometry the responsible phytotoxins 
present in leaves, flowers and twigs of Delonix regia (Boj. ex Hook.) Raf 
were identified as 4-hydroxy benzoic, chlorogenic .etc (46) 
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4 – HYDROXY BENZOIC ACID
CHLOROGENIC ACID
 Chou .C.H.et.al (1993) studied about the allelopathic substances and its 
interaction of  Delonix regia  (Boj.  ex Hook.)  Raf with other  species  of 
Delonix (47). 
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 Dutta et.al (1998) studied invitroly the aqueous extracts of plants such as 
Terminalia chebula, Punica granatum, Delonix regia (Boj. ex Hook.) Raf 
and Emblica officinals for  Dermatophytes(48). 
 Enikuomehin OA. et.al (1998) evaluated eleven ash samples from organs 
of nine tropical plants for their abilites to inhibit mycelial growth and 
sclerotial germination of a Nigerian isolate of sclerotium rolfsii on agar and 
in the soil. Ash sample from Delonix regia (Boj. ex Hook.) Raf stem wood, 
Magifera indica leaf and Vernonia amygdalina leaf were most effective as 
each totally inhibited mycelial growth of Sclerotium rolfsii in vitro(49).
 Polikarpov  I.et.al  (1999)  purified,  crystallized  studied  preliminary 
crystallographic study of a Kunitz –type trypsin inhibitor from  Delonix 
regia  (Boj. ex Hook.) Raf seeds. The Kunitz-type trypsin inhibitor from 
seeds  of  Flambyoant  has  been  purified  to  homogeneity  and  plate  like 
crystals suitable for X-ray analysis have been grown by the hanging-drop 
method, the structure has been  solved by molecular replacement using the 
known structure of Trypsin inhibitors from Erythrina Caffra seeds, Soya 
beans as search models(50).
23
 Muruganaandan.et.al  (2001)  screened  anti-inflammatory  and  analgesic 
activities of some Medicinal plants. The extracts of some medicinal plants 
were used at the dose rate of 300Kg,p.o. Aspirin (300mg/Kg,p.o) was 
employed  as  reference  drug.  Significant  anti-inflammatory  activity  was 
observed with  Delonix regia  (Boj. ex Hook.) Raf  bark. Pongamia Pinnata 
seeds, Psidium guavajava leaves and Aegle marmelos bark(51).
 Srinivasajn,.K.et.al  (2001) evaluated seventy percent ethanolic extracts 
(300mg/Kg p.o.) of Delonix regia (Boj. ex Hook.) Raf (Bark and Flowers), 
Psidium guavajava  leaves,  Aegle marmelos (Bark) exhibited significant 
anti-inflammatory  activities  in  rats.  However  Butea frondosa (Flower  ) 
Pinus  longifolia (Leaves)  Eugeia  jambolana didn’t  exhibit  significant 
activity. Pongamia pinnata (Seeds) and Delonix regia (Boj. ex Hook.) Raf 
(Bark and Flowers) exhibited significant ANALGESIC Activity(52).
 Oliva  ML  .et  al.  (2001)  isolated  a  serine  protienase  inhibitor   and 
purified from  Delonix regia  (Boj. ex Hook.) Raf  seeds a Leguminosae 
tree  of  the  Ceasalpinioidae  subflamily.  The  inhibitor  named  DrTI, 
inactivated  trypsin  and  Human  plasma  Kallikrein  with  K(i)  values 
2.19x108ֿM nd 5.25nM,respectivey. The primary sequence of the inhibitor 
was determined by Edman degradation and 185 amino acids showed that it 
belongs  to  the  Kunitz  type  inhibitor  family.  However  its  reactive  site 
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didn’t  contain contain Argine or Lysine at the putative reactive position or 
it was displaced when compared to other Kunitz type inhibitors(53).
 Pando SC et.al (2002) characterized a lectin from the Delonix regia (Boj. 
ex Hook.) Raf seeds which was purified by gel filtration on Sephadex G-
100 followed by Ion exchange chromatography on Diethyl amino –ethyl 
sepharose  and  reverse  –phase   HPLC  on  a  C  18  column. 
Haemagglutinating  activity  was  monitored  using  rat  erythrocytes.  DRL 
showed no specificity for human erythrocytes of ABO blood group(54).
 Sampaio  et  el.(2002)  determined  the  Primary  sequence  of  a  Kunitz 
Inhibitor which is isolated from Delonix regia (Boj. ex Hook.) Raf  seeds 
(55).
 Ankrah NA.et.al  (2003)  evaluated  the efficacy  and safety  of  a  herbal 
medicine used for the treatment of malaria. The resistance of Plasmodium 
falciparum to  Choloroquine has been reported in several countries. This has 
led to renewed interest in the development of herbal medicines that have the 
potential to treat malaria with little or no side effects. This study obtained a 
preliminary information on the safety and effectiveness of Jatropha curcas,  
Gossypium hirsutum,Physalis angulata and  Delonix regia  (Boj. ex Hook.) 
Raf used in treating malaria(56).
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 Krauchenco S.et al.(2003) studied the three dimensional  structure of a 
novel  Kunitz  (STI)  family  member,  an inhibitor  purified from  Delonix 
regia  (Boj.  ex  Hook.)  Raf  seeds  (DrTI)  was  solved  by  molecular 
replacement method and refined respectively. The structure has a classical 
beta-three  fold,  however  differently  from  canonical  grounds  of  such 
specificity are discussed(57).
 Ahmad I et al  (2003) screened for broad spectrum anti-bacterial,  anti-
fungal activities and potency of crude alcoholic extract and fractions of 
Delonix regia (Boj. ex Hook.) Raf. 70% Ethanolic crude extract was 
further  fractionated with Petroleum ether,  benzene,  acetone,  ethyl  acetate 
and methanol.  Anti-microbial  activity  of  crude  extract  and fractions  was 
tested against nine bacteria  six filamentous Fungi and a Yeast(58).    
 Seetharam et.al (2003) screened anti-microbial and analgesic activity of 
Delonix  regia  (Boj.  ex  Hook.)  Raf   and  Delonix  elata  gamble  Raf. 
Ethanolic extract of (delonix regia ) and (Delonix elata) have shown good 
anti-microbial activity (40 mg/10ml) and analgesic activity at the dose of 
200mg/Kg b.w(59)
 Mahmood .Z et .al (2003) evaluated Antioxidant properties of extracts 
and fractions of chichory, tulsi and gulmohar. Crude alcoholic extract of 
Ocimum  sanctum was  fractionated  into  ethyl  acetate  and  methanol. 
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Similarly [Cinchorium intybus] extracts in benzene and acetone,  alcoholic 
extract  of  Delonix  regia  (Boj.  ex  Hook.)  Raf  were  used. 
AlphaTocopherol and Butylated hydroxyl toluene were used as standard 
antioxidants(60).
 Venkateswara Rao et.al  (2004) screened the various fractions of crude 
methanolic  extracts  and  alkaloidal  fractions  of  Delonix  regia  (Boj.  ex 
Hook.)  Raf (flowers)  were  tested  for  their  anti-bacterial  activity  .  The 
water  soluble fractions of  methanolic  extract  was found to be effective 
against all the tested organisms(61).
 Aqil.  F  et  al(2004)  worked  on  Delonix  regia  (Boj.  ex  Hook.)  Raf 
(Flowers)  Camellia  sinesis  (Leaves)  Holarrhena  antidysentrica  (Bark) 
Lawsonia inermis (Leaves) Punica granatum (Rind), Terminalia chebula 
(fruits),  Terminalia  bellerica  (fruits).  Crude  extracts  of  above  showed 
broad spectrum antibacterial activity against all MRSA and a methicillin 
sensitive strains with inhibition zone size of 11mm to 27mm(62).
 Seneviratne.G  et  al  (2004)  screened  the  quality  of  different  Mulch 
materials and their decomposition and nitrogen release under low moisture 
regimens. Six leguminosal leaves including Delonix regia (Boj. ex Hook.) 
Raf leaves with a high phenolic and carbon content which were subjected 
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to  leaching  losses  of  these  fractions  underwent   a   change  in  their  N 
dynamics from net immobilization to mineralizations(63).
 Al.Bahry et al(2005) reported  Ganoderma colossum on Ficus altissima 
and Delonix regia (Boj. ex Hook.) Raf(64).
 Oswasis  et  al  (2005)  investigated  the  ethanolic  extracts  and  some 
fractions from 10 Indian medicinal plants including Delonix regia (Boj. ex 
Hook.)  Raf,  known for  antibacterial  activity  for  their  ability  to  inhibit 
clinical  isolates  of  β-lactamase  producing  methicillin-resistant 
Staphylococcus  aureus (MRSA)  and  methicillin-sensitive  S.aureus 
(MSSA). Synergistic interaction of plant extracts with certain antibiotics 
was also evaluated(65).
 Koster et al(2005) compared the various method of diffusive gels in thin 
films  with  conventional  extraction  techniques  for  evaluating  Zinc 
accumulation in plants and isopods of Delonix regia (Boj. ex Hook.) Raf 
(66).
 Jigna  Parekh   et  al  (2005)  screened  twelve  medicinal  plants  namely 
Abrus precatorius, Caesalpinia pulcherrima, Cardiospermum 
halicacabum,  Casuarina  equisetifolia,  Cynodox  dactylon,  Delonix  regia  
(Boj.  ex  Hook.)  Raf,  Euphorbia  hirta,  Euphorbia  tirucallic,  Ficus  
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benhalensis, Gmelina asiatica, Santalum album and Tecomella undulate for 
potential antibacterial activity against 5 medicinally important 
bacterial strains. From the screening experiment  Caesalpinia showed the 
best antibacterial activity(67).
 Farrukh  Aqil  et  al  (2006)  screened  the  methanolic  extracts  of  12 
traditionally used Indian medicinal plants including Delonix regia (Boj. ex  
Hook.) Raf for their antioxidants and free radical  scavenging properties 
using α-Tocopherol  and Butylated Hydroxy Toluene(BHT) as standard 
antioxidants.  A  fair  correlation  between  antioxidant  free  radical 
scavenging activity and phenolic content was observed among 9 plants. 
The tested plant extracts showed promising antioxidant and free radical 
scavenging activity thus justifying their traditional use(68).    
 Oluwasola Agbede.J  et  al  (2006) characterised the leaf  meals.  Protein 
concentrates and residues from some trophical leguminous plants like 
Butterfly  pea  (Cetrosema  pubescens),Devil  Bean  (Mucuna  pruiens) 
Flamboyant  flowers  (Delonix  regia  (Boj.  ex  Hook.)  Raf,  Bauhinia 
tomentosa,Wart  Wattle (Acacia  auriculiformis)  were  analysed  for  their 
nutrient  and anti-nutritional  content.  The  leaf  protein  concentrates(LPCs) 
were produced from the leaves by fractionation and characterized along with 
the fibrous residues(69). 
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 Sumitra, Chandra et al (2006) screened the in vitro anti-microbial activity 
and Phytochemical analysis of some medicinal plants including  Delonix 
regia (Boj. ex Hook.) Raf(70).
 Pandeya .S.C et al (2007) studied the genetic diversity in some perennial 
plant species within short distances.  Delonix regia  (Boj. ex Hook.) Raf 
depicted  highest  similarity  between  Lucknow  and  Agra.   Calotropis  
procera of Lucknow location was more closer to Gwalior than Agra. The 
results confirmed genetic diversity in the species as a means of adaptation 
to differing climo-edaphic variables(71).
 Ahmad.I  et  al  (2007)  screened  66  ethanolic  plant  extracts  including 
Delonix regia (Boj. ex Hook.) Raf against 9 different bacteria. Of these 39 
extracts  demonstrated  activity  against  6  or  more  test  bacteria.  Twelve 
extracts  showing broad spectrum activity  was tested against  Multidrug-
Resistant(MDR)  bacteria,Methicillin-resistant.  Staphylococcus 
aureus(MRSA)  and  extended  spectrum  β-lactamases  producing  Enteric 
bacteria(72).
 Hung.C.H et al (2007) designed degenerate primers based on all possible 
sequences of the N-terminal and C-terminal regions of Delonix regia (Boj. 
ex  Hook.)  Raf   trypsin  inhibitor.  Genomic  and  cDNA 
cloning,characterization  of  Delonix  regia  (Boj.  ex  Hook.)  Raf  trypsin 
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inhibitor  CDrTI  gene  and  expression  of  DrTI  in  E.coli.  Both  the 
recombinant  Delonix regia  (Boj. ex Hook.) Raf trypsin inhibitor (DrTI) 
and glutathione-S-transferase(GST). DrTI fusion protein exhibited a strong 
identical inhibitory effect on Trypsin activity(73).
 Anitha.K et al (2007) developed multiple natural dyes from flower parts 
of  Gulmohar  which  contains  flavonoids  such  as  Leuco  anthocyanin; 
caratenoids  such  as  lutein,  zeaxanthin,  violoxanthin,  neoxanthin, 
auroxanthin, 5,6-monoepoxylutein, antheraxanthin and flavoxanthin which 
are responsible for dyeing(74).
LUTEIN
VIOLOXANTHIN
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NEOXANTHIN
AUROXANTHIN
ANTHEROXANTHIN
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FLAVOXANTHIN
 Abiola.O.K  et  al  (2007)  investigated  the  inhibitive  effect  of  Delonix 
regia  (Boj.  ex  Hook.)  Raf extracts  to  reduce  the  corrosion  rate  of 
aluminium in acidic media. The study was a trial to find a low cost and 
environmentally  safe  inhibitor  to  reduce  the  corrosion  rate  of 
aluminium(75).
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3. PHARMACOLOGICAL ACTIVITIES
4. 1. OXIDATIVE STRESS (100-102)
Oxidative stress caused by free radicals has become an area of interest in 
understanding the process of human disease. However, interpretation of the 
term “oxidative stress” itself is often confused and the processes involved 
poorly understood. The term oxidative stress has rarely been defined in a 
universally accepted way. One accepted definition by Sies in 1991 is “ a 
disturbance in the pro-oxidant - antioxidant balance in favour of the former, 
leading to potential damage.” For a disturbance in this balance to occur, it 
follows that one or both of the following scenarios must be present.
1) A reduction in antioxidant.
2) An increase in reactive species.
1.1.Oxidative Stress and Diseases
It is quite certain that oxidative stress is the cause of a few human diseases. 
For  example,  formation  of  OH. by  ionising  radiation  is  thought  to  be 
responsible for diseases related to exposure to ionising radiation. The results 
of  exposure  to  high  O2 concentrations  and  the  various  congenital  and 
malnutritional  causes  of  depleted  antioxidants  may  also  be  attributed  to 
oxidative stress along with a few other diseases.
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However,  tissue  injury  itself  has  been  shown  to  be  a  major  cause  of 
oxidative stress via many pathways including the activation of phagocytes, 
release of metal ions and excess electron leakage from the electron transport 
chain. The current consensus suggests that oxidative stress is a consequence 
of tissue damage in many diseases rather than the major cause. The extent of 
the role played by oxidative stress in the pathogenesis of disease is thought 
to vary in different diseases. However, although oxidative stress may seldom 
be a primary cause of disease, its importance should not be dismissed as a 
potential target for therapeutic treatment.
1.2. Free Radical
A free radical is defined as “any species capable of independent existence 
that contains one or more unpaired electrons”. Generally, free radicals are 
more reactive than non-radicals (although an oxygen molecule O2 is classed 
as a free radical and is not particularly reactive) and will react with them to 
produce new free radicals in a chain reaction. It is these chain reactions that 
can lead to damage to molecules in the body. A reaction between two free 
radicals will result in the pairing of their unpaired electrons and therefore 
non-radicals are formed.
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1.2.1. Free Radical Mechanism
Free radicals attack three main cellular components. 
*  Lipids:  Peroxidation  of  lipids  in  cell  membranes  can  damage  cell 
membranes by disrupting fluidity and permeability. Lipid peroxidation can 
also  adversely  affect  the  function  of  membrane  bound  proteins  such  as 
enzymes and receptors.
* Proteins: Direct damage to proteins can be caused by free radicals. This 
can affect many kinds of protein, interfering with enzyme activity and the 
function of structural proteins.
• DNA:  Fragmentation  of  DNA caused by free radical  attack causes 
activation  of  the  poly(ADP-ribose)  synthetase  enzyme.  This  splits 
NAD+ to aid the repair of DNA. However, if the damage is extensive, 
NAD+ levels may become depleted to the extent that the cell may no 
longer be able to function and will die.
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The precise site of tissue damage by free radicals is dependent on the tissue 
and the reactive species involved. The overall damage caused by oxidative 
stress is often an accumulation of damage to many sites. Extensive damage 
can lead to death of the cell; this may be by necrosis or apoptosis depending 
on the type of cellular damage.
1.2.2. General Features of free radical reaction(103)
Free radical reactions take three distinct identifiable steps, such as
01. Initiation step: Formation of radicals.
02. Propagation step: It is the heart of  a free radical reaction.  In this step, 
the required free radical  is  regenerated repeatedly,  which would take the 
reaction to completion.
03. Termination step: Destruction of radicals.
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Fig : 4                        Free Radical reactions step wise
  I. Initiation Step
RH                               R*  + H
Organic Compound                Free Radical
 II. Propagation Step
R* + O2                      RO2*
RO2* + RH                        RO* + OH* + R*
                                                              Hydroxy radical
 III.  Termination Step
                        R* + H                            RH + I*
                                                               Stable free radical
                   RO2* + X                              Inactive Products
                                                               (Termination by inhibitor)
  Were X is a Chain Inhibitors.
161
1.2.3. Sources of Free radicals (104)
Two types of sources are:
1. Exogenous free radicals
2. Endogenous free radicals. 
1.2.3.1. Exogenous sources of free radicals
Exogenous  sources  of  free  radicals  are  automobile  exhaust  fumes,  UV 
radiation, interaction with chemicals, smoking of cigarettes, cigars, beedies, 
etc., (one puff of cigarette smoke is estimated to contain 1014 free radicals 
with > 4000 compound, including NO and NO2*), burning of organic matter 
during cooking, forest fires, etc, volcanic activities, radioactive decay-α,  β 
and  γ  radiation,  lightening  particularly  oxides  of  nitrogen,  byproduct  of 
oxygen metabolism (illness causes the body to produce greater amounts of 
harmful  radicals  than  in  healthy  condition),  industrial  effluents,  excess 
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chemicals, alcoholic intake, certain drugs, asbestos, certain pesticides, some 
metal ions, fungal toxins etc., inflict oxidative stress.
1.2.3.2. Endogenous sources of free radical
They  include  cyclooxygenation,  lipooxygenation,  lipid  peroxidation, 
neutrophils  stimulated  by  exposure  to  microbes,  reperfusion  of  ischemic 
organs, mechanism of xenobiotics and UV and ionizing radiation damage.
1.2.4. Types of free radicals
The most important free radicals in the body are the derivatives of oxygen, 
better known as reactive oxygen species.
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Table : 27                           Free radicals and their structure
S.No Types of free radicals Structure
01 Superoxide anion O2*
02 Hydroxyl radical OH*
03 Lipid peroxyl radical LO2*
04 Singlet oxygen O*
05 Hydrogen peroxide H2O2*
06 Hypochlorous acid HOCl*
07 Peroxy nitrate ONOO*
Other common free radicals
08 Hydroperoxyl HO2*
09 Peroxyl RO2*
10 Alkoxyl RO*
11 Hydrogen centered radicals (H*)
12 Carbon centered radicals (CCl3*)
13 Sulfur centered radicals (RS*)
1.2.4.1. Superoxide anions (O2*)(105)
Superoxide anion is the first reduction product of oxygen.  It is a base with 
the  equilibrium with  its  conjugate  acid,  the  hydroperoxyl  radical  HOO*. 
The formation of  superoxide takes  place spontaneously,  especially  in the 
electron  rich  aerobic  environment  in  vicinity  of  the  inner  mitochondrial 
membrane  with  the  respiratory  chain.   Superoxide  is  also  produced 
endogeneously by flavonoenzymes e.g., lipoxygenase and cyclooxygenase. 
The nicotinamide adenine dinucletide phosphate (reduced form) (NADPH) 
dependent   oxidase  of  phagocytic  cells,  a  membrane  associated  enzyme 
complex, constiitues  and example of deliberate high level O2* production. 
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Two molecules of superoxide rapidly dismutase to hydrogen peroxide and 
molecular  oxygen  and  this  reaction  is  further  accelerated  by  superoxide 
dismutase (SOD)
1.2.4.2. Hydrogen peroxide (H2O2)
Hydrogen peroxide is the most stable reactive oxygen species.  H2O2 is the 
primary  product  of  the  reduction  of  oxygen  by  various  oxidase  such  as 
xanthine  oxidases,  uricase,  D-amino  acid  oxidase  and  α-hydroxy  acid 
oxidase  localized in peroxisome.  Research shows that the H2O2 is the most 
effective  species  for  cellular  injury.   It  plays  an  important  role  in  the 
production of more  ROS molecules including HOCl (Hypochlorous acid) 
by the action of myeloperoxidase an enzyme present in the phagosomes of 
the neutrophils and  most importantly, formation of OH* via oxidation of 
transition metals.
H+ + Cl- + H2O2                          HOCl + H2O         
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The most important function of  H2O2  is its role as an intracellular signaling 
molecule.
H2O2  once produced by the above mechanism is removed by atleast three 
antioxidant enzyme systems, namely catalases, glutathione peroxidases and 
peroxidredoxins.
1.2.4.3. Hydroxy radicals (OH*) (106)
Hydroxy radical is highly reactive.  It may react with  any molecule present 
in the cells.  For this reason it is short lived.  The life span of OH* at 37°C is 
10-9 sec.   The  hydroxy  radical  is  formed  from  hydrogen  peroxide  in  a 
reaction catalyzed by metal ions (Fe+ or Cu+),  often bound in complex with 
different proteins or other molecules.  This is known as Fenton reaction.
H2O2 +  Cu+ / Fe2+                          OH* + OH- + Cu+/Fe3+………………………….(1)
Superoxide also plays an important role in connection with reaction 1 by 
recycling the metal ions.
Cu2+ / Fe3+  + O2*                         Cu+/Fe2+  + O2…………………………………….(2)
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The sum of reaction 1 and 2 is the Haber-Weiss reaction; Transition metals 
thus play an important role in the formation of hydroxy radicals.  Transition 
metals may be released from proteins such as ferritin and the (4Fe- 4S) 
center  of  different  dehydrases  by  reactions  with  O2*.   This  mechanism, 
specific  for  living cells,  has been called the  invivo  Haber-weiss  reaction. 
Lipid is very sensitive to OH* attack and initiates LPO (Lipid Peroxidation). 
The hydroxy radical is responsible for DNA damage and LPO.
1.2.4.4. Malonyldialdehyde (MDA)
Malonyldialdehyde is the major reactive aldehyde resulting from the 
peroxidation of biological membrane poly unsaturated fatty acid (PUFA),  a 
secondary product of LPO is used an indicator of tissue damage by  a series 
of chain reaction.  MDA is also a by product of prostaglandin biosynthesis. 
MDA is mutagenic and genotoxic agent that contribute to the development 
of human cancer.
1.2.4.5. Nitric Oxide (NO*)
167
Nitric oxide is an inorganic free radical gas.  It is synthesized by nitric oxide 
synthesis located in various tissues and plays active role in free radical 
tumour biology.  NO is synthesized enzymatically from L-arginine by NO 
synthase.
L-arginine + O2 + NADPH                            L –citrulline + NO + NADP +
Nitric oxide is another  free radical that has an important biological role. 
NO* produced in the body relaxes muscles in blood vessels and lowers 
blood pressure.  Many blood pressure lowering drugs e.g., Nitroglycerine, 
amyl nitrite.  But, excess NO* produced in  cases of severe infection can be 
harmful.  Unlike HO* or O2*, NO* is a much slower reacting radical and it 
combines with other free radical and inhibits further reaction or generate 
more reactive product.
1.2.5. Chemistry of free radical generation (107)
Free radicals can be generated both in vivo and In vitro by one of the 
following mechanisms.
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 Homolytic cleavage of covalent bond in which a normal molecule 
fragments into two, each fragment retaining one of the paired 
electrons.  Homolytic cleavage occurs less commonly in biological 
systems, as it requires high-energy input from UV light, heat or 
ionizing reaction.
 Loss of single electron from a normal molecule.
 Addition of an electron to normal molecule.
1.2.6. Mechanism of action of free radicals or ROS formation (108)
Oxygen in the atmosphere has two unpaired electrons and these unpaired 
electrons have parallel spins.  Oxygen is usually non reactive to organic 
molecules that have paired electrons with opposite spins.  This oxygen is 
considered to be in a ground (triplet or inactive) state and is activated to a 
singlet (active) state by two different mechanisms.
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a) Absorption of sufficient energy to reverse the spin on one of the unpaired 
electrons
O*         O*                             O*        O
                    Triplet Oxygen↑↓                     Singlet Oxygen↑↓
    Ground State                           Highly reactive
b) Monovalent reduction (accept a single electron)
Superoxide is formed in the firs monovalent reduction reaction, which 
undergoes further reduction to form H2O2. H2O2 is further gets reduced to 
hydroxyl radicals in the presence of ferrous salts (Fe2+).  This reaction was 
first described by Fenton and later developed by Haber and Weiss.
                                                        
O*         O*  Monovalent reduction   O*          O       Monovalent reduction  H:O       O:H
Fenton Reaction
Fe2+ + H2O2                    Fe3+ + OH- + OH *
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Haber Weiss Reaction 
H2O2 + OH-                           H2O + O2 + H-
H2O2 + O2*-                         O2 + OH- + OH*
1.2.7. Diseases caused by the free radicals(109-111)
The free radicals are generated during the normal metabolic reaction in the 
body.  Free radicals are very unstable and react quickly with other 
compounds, trying to capture the needed electron to gain stability.
Some free radicals arise normally during metabolism sometimes the body’s 
immune system cells purposefully create free radicals to neutralize virus and 
bacteria.  However environmental factors such as pollution, cigarette smoke 
and herbicide can also produce free radicals.  Normally the body can handle 
free radicals but if antioxidants are unavailable or if the free radical 
production is excess then damage can occur.
The formation of free radicals and the occurrence of oxidative stress is a 
common component of parkinsons disease have reduced glutathione levels 
and free radical damage is found in the form of increased lipid peroxidation 
and oxidation of DNA bases.
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The disease occur due to free radicals area as follows:
 Cancer and other Malignancies
 Lipid peroxidation and Artherosclerosis 
 . Lung disease 
 Infertility 
 Arthiritis 
 Diabetes Mellitus 
 Muscle Damage
 Inflammation 
1.3. Antioxidants(113)
Antioxidants have been defined “as any substance which delays or inhibits 
oxidative damage to a target molecule.” In general, an antioxidant in the 
body may work in one of five ways.
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• Replacing damaged “target molecules” 
• Keeping formation of reactive species to a minimum 
• Repairing damaged “target molecules” 
• Binding metal ions required for formation of highly reactive species 
(such as OH.) 
• Scavenging reactive species either by using enzymes or directly by 
reaction whereby the antioxidant itself would be used up. 
1.3.1. Antioxidants system/System of  antioxidant.
The body had developed several endogenous antioxidant systems to deal 
with the production of reactive oxygen intermediates (ROI).  These systems 
can be divided into:
Fig: 5 Classification of Antioxidants
Antioxidants
Enzymatic                                                          Non Enzymatic
  Superoxide dismutase        Antioxidant enzyme                              Oxidative enzyme
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                                              Cofactors (selenium,                              inhibitors 
    Catalase                            Coenzyme Q10)                                   (Aspirin, Ibuprofen) 
                                                 
   Glutathione peroxidase          Transition metal                           Radical Scavengers 
                                                        Chelator (EDTA)                         (Vit.C & E )
Enzymatic  antioxidants  include  superoxide  dismutase  (SOD)  which 
catalyses  the  conversion  of   O2- to  H2O2 and  H2O;  catalase  which  then 
converts H2O2 to H2O and  O2,  and glutathione peroxidase which reduces 
H2O2 to H2O.
Both Vit C and GSH have been implicated in the recycling of α -t-cpherol 
radicals.   In  addition,  the  trace  elements  such  as  selenium,  manganese, 
copper  and  Zinc  also  play  important  roles  as  nutritional  antioxidant 
cofactors.  Selenium is a  cofactor for the enzyme glutathione peroxidase and 
manganese, copper and Zinc are cofactors for SOD.  
Zinc also acts to stabilize the cellular metallothionein pool, which has direct 
free  radical  quenching  ability.   Glutathione  is  recycled  by  nicotinamide 
adenine  dinucleotide  phosphate  (reduced  form),   which  is  facilitiated  by 
glutathione reductase.
174
1.3.2. Enzymatic Antioxidants
1.3.2.1. Superoxide dismutase (SOD) (114&115)
SOD is an endogenously produced intracellular enzyme present essentially 
in every cell in the body.  Cellular SOD is actually represented by a group of 
metalloenzymes with various prosthetic groups.  The prevalent  enzyme is 
cuprozinc (Cu Zn) SOD which is a stable  dimeric protein (32,000).
SOD appears in 3 forms according to the catalytic metal present in the active 
site.
i. Cu-Zn Sod in the cytoplasm and contains copper and zinc as metal 
cofactors.
ii. Mn-SOD in the mitochondria and contain Mn.
iii. Extracellular  SOD recently  has  been  described  contains  copper 
(CU-SOD).
2O2-   2H+ +  SOD                             H2O2 + O2
SOD scavenges both intracellular and extra cellular superoxide radical  and 
prevents the lipid peroxidation of plasma membrane. However it  should be 
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conjugated  with  catalase  or  GPx  to  prevent  the  action  of  H2O2,  which 
promotes  the  formation  of  hydroxyl  radicals.   SOD also  prevents  hyper 
activation and capacitation induced by superoxide radicals.
1.3.2. 2. Glutathione peroxidase (GPx) reductase/enzyme (GRD) (116&118)
It is the tetrameric protein 85,000 D and has 4 atoms of Selenium (Se) bound 
as seleno-cysteine moieties that confer the catalytic activity.  One of the 
essential requirement is glutathione as a cosubstrate.
Glutathhione peroxidase  reduces   H2O2  to   H2O by oxidizing glutathione 
(GSH) reproduction of the oxidized form of glutathione (GSSH) and then 
catalyzed  by  glutathione  reductase.    These  enzymes  also  requires  trace 
metal  factors  for  maximal  efficiency,  including  selenium for  glutathione 
peroxidase; copper, zinc or manganese for SOD; and iron for catalase.
H2O2 + 2 GSH                                 GSSG + 2 H2O  (Glutathione 
Peroxidase)
GSSG + NADPH + H+                    2 GSH + NADP+ (Glutathione Reductase)
GSH    = Reduced glutathione.   GSSG  = Oxidised glutathione.
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1.3.2.3. Catalase
Catalase is a protein enzyme present in most aerobic cells in animal tissues 
and also present in all body organs being especially concentrated in liver and 
erythrocytes, while brain, heart, skeletal muscle contains only low amounts.
Catalase and glutathione peroxidase decomposes hydrogen peroxide to water 
and molecular oxygen.
2H2O2               Catalase                  H2O + ½ O2 
1.3.3. Non enzymatic antioxidants
1.3.3.1. α -Tocopherol (Vitamin E)
Vitamin E is the major lipid soluble antioxidant found in cells.  Tocopherols 
are present in oils, nuts, seeds, wheat germ and grains.  In nature, 8 
substances have been found to have vitamin E activity, d-α, d-β , d-γ  and d-
δ  tocopherol (Which differ in methylation site and side chain saturation) and 
d-α, d-β , d-γ  and d-δ  tocotrienol.
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d-α tocopherol has the highest biopotency and its activity is the standard 
against which all others must be compared.  It is the predominant isomer in 
plasma.  Vitamin E is an essential nutrient that functions as an antioxidant in 
the human body.  Absorption is believed to be associated with the intestinal 
fat absorption.  Approximately 40% of the ingested tocopherol is absorbed.
The main function of tocopherol is to prevent the peroxidation of membrane 
phospholipids and avoid cell membrane damage through its antioxidant 
action.
α - tocopherol + LOO*                               α-tocophenol* + LOOH
α-tocophenol + LOO                                         LOO - α-tocophenol
α-tocopherol has been shown to be capable of reducing ferric ion (i.e. to act 
as a pro-oxidant.  Moreover, the ability of α-tocopherol to act as a pro-
oxidant (reducing agent) or antioxidant depends on  whether all of the α-
tocopherol becomes consumed in the conversion from ferric to ferrous ion.
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1.3.3.2. Ascorbic Acid 
Ascorbic acid is a water soluble antioxidant present I citrus fruits, potatoes, 
tomatoes and green leafy vegetables.  Humans are unable to synthesise L-
ascorbic acid from d-glucose due to the absence of the enzyme L-galaco 
acetone oxidase.  It is a water soluble chain  breaking antioxidant.  It 
scavenges free radicals and reactive oxygen molecules which are produced 
during metabolic pathways of detoxification.  It also prevents formation of 
carcinogens from precursor compounds.
One important property is its ability to act as a reducing agent (Electron 
donor).   Ascorbate is more potent than α-tocopherol  in inhibiting the 
oxidation of low density lipoprotein (LDL) in a cell free system.  The 
concentration of ascorbate use to inhibit LDL oxidation (40-60 µm) is 
within the normal plasma range.  Vitamin C supplementation in animals 
leads to increased plasma and tissue levels of Vitamin E.
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1.3.3.3. Coenzyme Q10
It is an excellent antioxidant with characteristics similar to vitamin E.  it is a 
powerful immune system stimulant.  It is also known to have a great number 
of other useful characteristics including cardiovascular benefits, anti-ageing, 
gum disease and cellular energy.
1.3.4. Mechanism of action of Antioxidants
There are
 Physical barriers preventing ROS generation or ROS access to important 
biological sites. E.g. UV filters, cell membranes.
 Chemical traps/sinks ‘absorb’ energy and electrons quenching ROS. E.g. 
carotenoids, anthocyanidins.
 Catalytic  system  neutralize  or  diverts  ROS.  E.g.  SOD,  catalase  and 
glutathione peroxidase.
 Binding/inactivation of  metal  ion prevents generation of ROS by Haber-
Weiss reaction. E.g. Ferritin, caeruloplasmin, catechins.
 Sacrificial and chain breaking antioxidants scavenge and destroy ROS. 
E.g. Ascorbic acid (Vit.  C), tocopherols (Vit.  E), uric acid, glutathione 
and flavanoids.
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2. 0  PHARMACOLOGICAL EVALUATION OF DELONIX REGIA 
(BOJ. EX HOOK.) RAF. LEAVES FOR ANTIMICROBIAL 
ACTIVITY
Medicinal plants are a source of great economic value in the Indian 
subcontinent.  Herbal medicine is still the mainstay of about 75-80% of the 
whole population mainly in developing countries for primary health care 
because of  better cultural acceptability, better compatibility with the human 
body and fewer side effects.  However the last few years have seen a major 
increase in their use in the developed world.
Now a day multiple drug resistance has developed due to the indiscriminate 
use of commercial anti-microbial drugs commonly used in the treatment of 
infectious disease.  Therefore there is a need to develop alternative anti-
microbial drugs for the treatment of infectious disease from medicinal 
plants.  In addition to this problem antibiotics are sometimes associated with 
adverse effects on the host including hypersensitivity, immune suppression 
and allergic reaction.
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Several screening studies have been carried out in different parts of the 
world.  There are several reports on the anti-microbial activity of different 
herbal extracts in different regions of the world.  This situation forced 
scientist to search for new anti-microbial substances. Given the alarming 
incidence of antibiotic resistance in bacteria of medical importance, there is 
a constant need for new and effective therapeutic agents. 
Because of the side effects and the resistance that the pathogenic 
microorganisms built against antibiotics, recently much attention has been 
paid to extracts and biologically active compounds isolated from plant 
species used in herbal medicine.
Anti-microbials of plant origin have enormous therapeutic potential. Plant-
based anti-microbials represent a vast untapped source of medicines  and 
further exploration of plant anti-microbials needs to occur.  They are 
effective in the treatment of infectious diseases while simultaneously 
mitigating many of the side effects that are often associated with synthetic 
anti-microbials.
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All plants containing active compounds are important.  The beneficial 
medicinal effects of plant materials typically result from the combinations of 
secondary products present in the plants.  In plants, these compounds are 
mostly secondary metabolites such as alkaloids, steroids, tannins and phenol 
compounds which are synthesized and deposited in specific parts  or in all 
parts of plants.  These compounds are more complex and specific and are 
found in certain taxa such as family, genus and species but the heterogeneity 
of secondary compounds is found in wild species.
In the present work the leaf ethanolic extract was evaluated for their anti-
microbial properties using bacterias and fungi.
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2.1. ANTIMICROBIAL EVALUATION OF DELONIX REGIA (BOJ. 
EX HOOK.) RAF. LEAVES (131&132)
The microbiological assay is based upon a comparison of the inhibition of 
growth of microorganisms by measured concentrations of the antibiotics to 
be  examined  with  that  produced  by  known concentrations  of  a  standard 
preparation of the anti-biotic having a known activity. 
The  anti-microbial  activity  of  Delonix  regia  (Boj.  ex  Hook.)  Raf.   leaf 
ethanolic extracts were studied by the presence of zones of inhibition against 
microorganisms. 
The following microorganisms were used for our studies. 
 Strepto cocci
 Staphylo cocci
 Proteus vulgaris
 Escherichia coli 
 Pseudomonas aeuroginosa 
 Klebsiella aerugenes 
 Candida albicans
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5. PREPARATION OF NUTRIENT BROTH FOR BACTERIA 
Ingredients:
Beef extract 1gm
Peptone 1 gm
Sodium chloride 0.5 gm
Distilled water 100 ml
Procedure: 
The accurately weighed quantities of above ingredients were dissolved in 
distilled water and pH was adjusted to 7.4 and sterilized by autoclaving. 
PREPARATION  OF  SABOURAUD  DEXTROSE  BROTH  FOR 
FUNGI 
Ingredients:
Dextrose - 4gm
Peptone - 1gm
Distilled Water - 100ml
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Procedure:
The weighed quantities of ingredients were dissolved in distilled water and 
pH was adjusted to 5.2 and sterilized by autoclaving. 
PREPARATION OF SLANTS 
To the broth 2% of agar was added to prepare nutrient agar and sabouraud 
dextrose agar media. 
PREPARATION AND STANDARDIZATION OF INOCULUM 
Each  bacterial  and  fungi  pure  cultures  were  transferred  into  100ml  of 
nutrient broth (NB) and Sarbouraud’s Dextrose Broth (SDB) respectively. 
The inoculated broths were incubated at 37°C fro 24 hours and 27°C for 72 
hours fro bacterial and fungi respectively. After incubation inoculum were 
standardized to 108 CFU/ml for bacteria and 106CFU/ml for fungi by colony 
forming unit method. 
2.2 ANTIMICROBIAL ACTIVITY OF  DELONIX REGIA  (BOJ.  EX 
HOOK.) RAF. BY DISC DIFFUSION METHOD 
Sample Preparation
The ethanolic  extract of  DELONIX REGIA (BOJ. EX HOOK.) RAF.  was 
dissolved in 10% Dimethyl formamide (DMF) to a final concentration of 
50mg/ml, 75mg/ml,  100mg/ml and 200mg/ml.  The sterile discs (6mm in 
diameter)  were  impregnated  with  10µl  of  the  extracts  and tested  against 
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microbial  cultures.  (100  sterile  discs  were  taken  and  soaked  in  1ml  of 
extracts of various concentrations).
Antibacterial Activity
Muller  Hinton  agar  medium  was  prepared  and  transferred  into  sterile 
petriplates.  200µl of the standardized bacterial inoculum was spread on agar 
medium  using  sterile  cotton  swab.  The  extracts  impregnated  discs  were 
placed on the inoculated agar medium.  Negative control was prepared using 
the  same  solvent  employed  to  dissolve  the  plant  extracts.   Amikacin 
5µg/disc was used as positive reference standard to determine the sensitivity 
of each microbial species tested.  All the petriplates were incubated at 370C 
for  24  hours.   After  the  incubation  diameter  of  zone  of  inhibition  was 
measured. 
Anti fungal Activity
Sarbouraud’s dextrose agar medium was prepared and transferred into sterile 
petriplates.  200µl of the standardized fungal inoculum was spread on agar 
medium using sterile  cotton swab.   The extracts  impregnated  discs  were 
placed on the inoculated agar medium.  Negative control was prepared using 
the same  solvent  employed to  dissolve  the  plant  extracts.   Ketoconazole 
10µg/disc  was  used  as  positive  reference  standard  to  determine  the 
sensitivity  of  each  microbial  species  tested.   All  the  petriplates  were 
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incubated at 270C for 72 hours.  After the incubation diameter of zone of 
inhibition was measured.
Table: 28      Anti- microbial activities of  Delonix regia (Boj. Ex Hook.) 
Raf.  by disc diffussion method
S.NO MICROORGANISMS
ZONE     OF INHIBITION
(ZI) in mm
500µ g 750µ g 1000µ g 2000µ g Std
I
BACTERIA                                       Amikacin
                                                                                                      5µ g/disc
01 Strepto cocci -- -- 12 14 16
02 Staphylococcus aureus  -- 10 11 13 15
03 Proteus vulgaris -- -- -- -- 18
04 Escherichia coli -- 10 12 14 16
05 Pseudomonas aeuroginosa 18 20 24 26 22
06 Klebsiella aerugenes -- -- 10 11 22
II
                 FUNGI                                                                 Ketoconazole
                                                                                                     10µ g/dis
c
01 Candida albicans -- -- -- 17 16
-- No inhibition zone
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3.0  PHARMACOLOGICAL  EVALUATION  OF  ISOLATED 
COMPOUNDS  S8 AND  F1 FOR  IN  VITRO AND  EX  VIVO 
ANTIOXIDANT ACTIVITIES
The  isolated  Sterol  S1 and  the  flavanoid  F1  were  subjected  for  their 
antioxidant potential by means of in vitro and ex vivo  antioxidant studies. 
The various methods employed were as follows:
In Vitro Methods
 Reducing power ability.
 Nitric Oxide radical scavenging assay.
 DPPH radical scavenging assay
Ex Vivo Methods
 Assay of Lipid Peroxidation method.
Before determining the antioxidant potential of the isolated compounds, the 
Total Phenolics content of the crude alcoholic extract was determined in 
order to predetermine the antioxidant potential of the plant or not.
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3.1. Estimation of Total Phenolic Content of Delonix regia (Boj. ex  
Hook.) Raf.  leaves(117&118)
Total soluble Phenolics of the extracts were determined with Folin-Ciocalteu 
reagent using gallic acid as a standard.  100mg of the extract was extracted 
with 20ml of methanol (20*5) and filtered.  The filtrate is made up to 100ml 
with methanol.  2 ml of the content is taken and made up to 3ml by addition 
1 ml of water. To the contents add 0.5ml of Folin-Ciocalteu reagent and kept 
aside for 3 min. to this add 2ml of 20% sodium carbonate  solution and 
mixed thoroughly.  The contents were placed in boiling water bath for 1 min 
and cooled down. In the similar way the standard gallic acid is also prepared 
using 50mg of gallic acid.  The absorbance of standard and sample were 
measured at 650nm against blank.
Total Phenolics =   Sample reading X Standard weight X Sample dilution x 100
          Standard reading X Standard dilution X Sample weight
                                          1.5423 X 52.3 X 5 X 100 X 100
Total Phenolic  content =
                                               0.7954 X 50 X 50 X 102 
Total Phenolic content= 19.8845mg/100gms as Gallic acid equivalents.
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3.2. Antioxidant Methods
3.2.1. In Vitro Methods
3.2.1.1. Reducing power ability(119-121)
The reducing power ability of S8 and F1 was investigated by the Fe3+ - Fe2+ 
transformation in the presence of extract. The reductive ability was 
measured by mixing 1.0 ml of the sample prepared with distilled water to 
2.5 ml of phosphate buffer (0.2 m, pH 6.6) and 2.5 ml of 1% potassium 
ferricyanide and incubated at 50°C for 30 min.  After that 2.5 ml of 
trichloroacetic acid (10%) were added to the mixture and centrifuged for 10 
min at 3000g, 2.5 ml from the upper part were diluted with 2.5ml of water 
shaken with 0.5ml of fresh 0.1% ferric chloride.  The absorbance was 
measured at 700nm using UV spectrophotometer.  The reference solution 
was prepared as above and contain water instead of the samples.  Increased 
absorbance of the reaction mixture indicated increased reducing power. 
Vitamin C is used as the standard.
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Table: 29   Total Reducing ability of  S8 and F1 of Delonix regia (Boj. ex 
Hook.) Raf leaves
6. Control = 0.021 
7.
S
Sample Concentration µ g/ml Absorbance
01 S8 125
250
500
750
1000
0.046 ±  0.0023*
0.068 ±  0.0017***
0.076 ±  0.0008***
0.086 ±  0.0020***
0.100 ±  0.001***
02 F1 125
250
500
750
1000
0.064 ±  0.0067***
0.099 ±  0.0029***
0.109 ±  0.0015***
0.124 ±  0.0046***
0.145 ±  0.004***
03 Vit C 01
02
03
04
05
0.076 ±  0.0054***
0.1117 ±  0.0015***
0.1563 ±  0.0075***
0.1803 ±  0.005***
0.2270 ±  0.007***
Values are Mean ±  SEM                                        n = 03
*** P < 0.001 as compared to the Control group
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* P < 0.05 as compared to the control group
3.3.1.2. DPPH radical scavenging assay(120,122-125) 
The free radical scavenging activity of isolated compounds S8 and F1 of 
Delonix regia (Boj. ex Hook.) Raf. was measured in vitro by 1,1-diphenyl-2-
picryl hydrazyl (DPPH) assay. The hydrogen donating ability of the 
compounds were determined in the presence of DPPH stable radical.  The 
isolated compounds and stock solution (1mg/ml) was diluted to required 
concentrations in methanol.  One milliliter of 0.1mM DPPH methanol 
solution was added to 1.0ml of sample solution of different concentration 
and allowed to react at room temperature.  After 30min the absorbance was 
measured at 517 nm.  The values obtained were converted into percentage 
antioxidant activity (AA%) using the following formula
                               [(Abs Control – Abs Sample) X 100]
AA% =                                  Abs Control
Vit. C (Ascorbic acid) is used as the standard.  The IC50 values are calculated 
by linear regression of plots.
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Table: 30  DPPH radical scavenging assay of  S8 and F1 of Delonix regia 
(Boj. ex Hook.) Raf leaves
8. Control = 0.4810
9.
S
Sample Concentration  (µ g/ml) % Inhibition 10.IC50
01 S8
125
250
500
750
1000
20.09 ±  2.069
31.11 ±  2.285
41.79 ±  1.590
50.94 ±  2.542
63.54 ±  1.434
720
02 F1
125
250
500
750
1000
30.55 ±  2.911
46.42 ±  1.988
65.62 ±  2.609
78.31 ±  0.8133
87.31 ±  1.477
300
03 Vit C
01
02
03
04
05
26.26 ±  1.330
39.08 ±  0.9836
48.16 ±  4.429
65.90 ±  2.359
80.52 ±  0.6838
3.1
Values are Mean ±  SEM                                        n = 03
P < 0.001 as compared to the Control group
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3.3.1.3. Nitric oxide radical scavenging assay(120, 126&127)
Nitric oxide generated from sodium nitroprusside in aqueous solution at 
physiological pH interacts with oxygen to produce nitric ions, which were 
measured by Griess reagent.   The reaction mixture with a final volume of 3 ml per 
tube containing 2.0 ml of 10 mM sodium nitro prusside in phosphate buffer saline 
solution and was incubated with 1.0 ml of different concentration of test 
compounds (S8 and F1) dissolved in phosphate buffer (0.025 M, pH 7.4 ) and the 
tubes were incubated at 25°C for 150min.  Control experiments were carried out 
without the test compounds but with equivalent amount of buffer solution. There 
after 0.5ml of incubation solution was removed and diluted with 0.5ml of Griess 
reagent (1% Sulphanilamide in 2% O –Phosphoric acid and 0.1% napthylene 
diamine hydrochloride) and allowed to react for 30 min.  The absorbance of the 
chromophore formed during diazotisation of nitrite with sulphanilamide and 
subsequent coupling with napthylene diamine dihydrochloride was read at 546nm. 
The percentage inhibition was calculated using the formula                   
                                                     (Ao – A1)  
  Percentage inhibition (I)  =     X 100
                                                                     Ao
Where Ao is the absorbance of the control reaction and A1 is the absorbance of the test 
compound.  The experiment was done using Vitamin C as Standard.
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Table: 31    Nitric Oxide radical scavenging assay of  S8 and F1 of 
Delonix regia (Boj. ex Hook.) Raf  leaves
11.Control = 0.4476
S.No Sample Concentration  (µ g/ml) % Inhibition
IC50
01 S8
125
250
500
750
1000
1.197 ±  0.3382
5.093 ±  1.524*
47.86 ±  3.028***
63.91 ±  1.444***
67.30 ±  1.961***
530
02 F1
125
250
500
750
1000
29.75 ±  1.5970***
46.83 ±  1.135***
64.50 ±  0.4421***
76.37 ±  0.8580***
80.82 ±  0.8228***
310
03 Vit C
01
02
03
04
05
20.73 ±  1.7840***
34.52 ±  0.8792***
56.42 ±  0.9635***
73.04 ±  0.1637***
78.22 ±  0.5685***
2.7
Values are Mean ±  SEM                                        n = 03
*** P < 0.001 as compared to the Control group
* P < 0.05 as compared to the control group
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3.3.2. Ex Vivo Methods
3.3.2.1.  Estimation of TBAR’s (Lipid Peroxidation Method)(128-130)
TBA reacts with malonyldialdehyde (MDA) to form a diadduct, a pink 
chromogen, which can be detected spectrophotometrically at 532nm.  The liver 
homogenate were prepared from normal male rats (250gms).  The perfused liver 
was isolated and 10% w/v homogenate was prepared with homogenizer with 
0.15M KCl.  The homogenate was centrifuged at 800g for 15min and clear cell 
free supernatant was used for the study of in vitro lipid peroxidation.   Various 
concentrations of the isolated compounds of  S8 and F1 are dissolved in methanol 
and taken in test tubes.   One ml of 0.15M KCl and 0.1ml of homogenate were 
added to the test tubes.  Peroxidation was initiated by adding 100µl of 0.2mM 
ferric chloride.  After incubation at 37°C for 30min, the reaction was stopped by 
adding 2ml of ice cold hydrochloric acid (0.25N) containing 15% trichloroacetic 
acid (TCA), 0.38% TBA and 0.5% BHT.  The reaction mixture was heated at 80°C 
for 60min.  The samples were cooled and centrifuged and the absorbance of the 
supernatant was measured at 532nm. 
                                                        (Ao – A1)  
  Percentage inhibition (I)  =    X 100
                                                               Ao
Where Ao is the absorbance of the control reaction and A1 is the absorbance of the 
test compound.  The experiment was done using Vitamin C as Standard.
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Table: 32  Lipid peroxidation assays of  S8 and F1 of Delonix regia (Boj. 
ex Hook.) Raf  leaves
12.Control = 0.4218
S.No Sample Concentration  (µ g/ml) % Inhibition IC50
01
S8
125
250
500
750
1000
03.44 ±   1.116 
14.50 ±  2.356***
47.91 ±  0.44***
62.97 ±  1.750***
75.53 ±  1.396***
520
02
F1
125
250
500
750
1000
19.21 ±  3.573**
40.33 ±  1.376***
50.99 ±  0.8967***
65.88 ±  1.644***
84.25 ±  1.096***
480
03
Vit C
25
50
100
250
500
32.63 ±  2.330***
47.23 ±  0.6253***
61.75 ±  1.397***
70.82 ±  0.7988***
87.12 ±  1.819***
60
Values are Mean ±  SEM                                        n = 03
*** P < 0.001 as compared to the Control group
• P < 0.05 as compared to the control group.
•
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PHYTOCHEMICAL INVESTIGATION
01. COLLECTION AND AUTHENTICATION
Delonix regia (Boj. ex Hook.) Raf. leaves were collected from in and around 
areas of Madurai    Medical    College    campus,    Madurai and    the same 
was   authenticated by  Dr. D. Stephen, M. Sc, Ph.D,  Professor & HOD, 
Department of Botany, The American college, Madurai.
02. MACRO-MORPHOLOGICAL STUDY(76)
Morphology is the study of the form of an object whilst morphography is the 
description of that form.  A number of different bases may be used on the 
classification of drugs and morphological studies play a great role in this 
respect.  The application of morphology in drug analysis lies in the field of 
crude drugs where the material is known to occur in a particular form, it can 
be studied for the whole drug i.e., macro-morphography or gross 
morphology study of cell characteristics i.e. cytomorphology or study of 
morphological character in a particular level.  
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The majority of natural products used as drugs are derived from plants or 
parts of plants.  Characteristically the higher plants consists in the vegetative 
phase of roots, stems, leaves with flowers, fruits and seeds in the 
reproductive cycle.  Modifications of the above structures are frequently 
present such as rhizomes (underground stems), stipules, bracts (modified 
leaves), tendrils (modified stem), stolons 
(runners with a stem structure) etc., Interpretations of the morphological 
characteristics based on different parameters, for all the plant organs as 
above gives us a first hand tool to know the features of whole or powdered 
drugs and adulterants of commercial significance. 
 It is most useful only for only a part of plant to be used, either because the 
active constituents is only found in a particular part or because of economic 
consideration, which dictate the collection of certain parts of the whole 
plant.  Most species of a plant are readily distinguishable in their natural 
state, but collection, preparation and drying procedure distortion of that 
natural form, making recognition more difficult.  Natural variations in size 
and shape are common because of the environmental factors where 
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Macro-morphology plays an important role for preliminary evaluation of the 
crude drugs.  Based upon the anatomical structure of the plant the groups or 
the parts of plant commonly used for different therapeutic categories are 
leaves, bark, flowers, fruits and seeds, wood, herb or aerial parts, sub 
terranean organ etc.
Table:  01 Macro-morphological  evaluation  of  Delonix  regia (Boj.  ex 
Hook.) Raf leaf
S.No PARAMETER MORPHOLOGY
Leaf - Compound
01 Surface Glabrous
02 Lamina Oval
03 Margin Entire
04 Apex Obtuse
05 Base Slightly asymmetrical
06 Venation Reticulate
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03. ORGANOLEPTIC EVALUATION OF POWDERED LEAF 
Colour  : Dark green.
Odour  : Odourless.
Taste    : Slightly bitter.
Texture : Gritty.
Size      : Uneven sized coarse particles.
04. PHYSICAL CONSTANTS (77&78)
The following physical constants were carried out for the leaf and flower 
powder:
1. n – Hexane soluble extractive (HSE)
2. Petroleum ether soluble extractive 40 - 60 (PESE).
3. Chloroform soluble extractive (CSE).
4. Ethyl acetate soluble extractive (EASE).
5. Acetone soluble extractive (ASE).
06.        Methanol soluble extractive (MSE).
07. Water soluble extractive (WSE).
8. Total ash
9. Sulphated ash.
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4. 1. EXTRACTIVE VALUES
This method determines the amount of active constituents in a given amount 
of medicinal plant material when extracted with solvents.   It is employed for 
that material for which no chemical or biological assay method exists.  As 
mentioned in different official books the determination of water-soluble and 
alcohol soluble extractives,  is used as a means of evaluating crude drugs 
which are not readily estimated by other means.
The  extraction  of  any  drug  with  a  particular  solvent  yields  a  solution 
containing  different  phytoconstituents.   The  composition  of  these 
phytoconstituents in that particular solvent depends upon the nature of the 
drug and solvent used.  The use of a single solvent can be the means of 
providing preliminary information on the quality of a particular drug sample; 
for example, in a drug where the extraction procedure for the constituents 
commences with water as the solvent, any subsequent aqueous extraction on 
the re-dried residue will give a very low yield of soluble matter.
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4.1.1 n-Hexane soluble extractive [HSE]
5gms of the air dried powder of Delonix regia was macerated with 100ml of 
n – Hexane  in a stoppered flask, shaking frequently during the first 6 hours 
and allowed to stand for  18 hrs.  Thereafter  it  was filtered rapidly taking 
precaution  against  the loss  of  solvent.  Evaporate  25 ml  of  the filtrate  to 
dryness in a tarred flat bottom shallow dish dried at 105oC, and weighed. 
Percentage n-Hexane soluble extractive was calculated with reference to the 
air-dried plant.
4.1.2 Petroleum ether soluble extractive [PESE].
5gms of the air dried powder of Delonix regia was macerated with 100ml of 
Petroleum ether 40-60 in a stoppered flask, shaking frequently during the 
first  6 hours   and allowed to stand for 18 hrs. Thereafter it  was filtered 
rapidly taking precaution against the loss of solvent. Evaporate 25 ml of the 
filtrate to dryness in a tarred flat bottom shallow dish dried at 105oC, and 
weighed.  Percentage Petroleum ether soluble extractive was calculated with 
reference to the air-dried plant.
204
4.1.3 Chloroform Soluble Extractive [CSE]
5gms of the air-dried powder of Delonix regia was macerated with 100ml of 
chloroform in a stoppered flask, shaking frequently during the first 6 hours 
and allowed to stand for  18 hrs.  Thereafter  it  was filtered rapidly taking 
precaution  against  the loss  of  solvent.  Evaporate  25 ml  of  the filtrate  to 
dryness in a tarred flat bottom shallow dish dried at 105oC and weighed. 
Percentage n-Hexane soluble extractive was calculated with reference to the 
air-dried plant.
4.1.4 Ethyl Acetae Soluble extractive [EASE].
5gms of the air-dried powder of Delonix regia was macerated with 100ml of 
ethyl acetate in a stoppered flask, shaking frequently during the first 6 hours 
and allowed to stand for  18 hrs.  Thereafter  it  was filtered rapidly taking 
precaution  against  the loss  of  solvent.  Evaporate  25 ml  of  the filtrate  to 
dryness in a tarred flat bottom shallow dish dried at 105oC, and weighed. 
Percentage ethyl acetate soluble extractive was calculated with reference to 
the air-dried plant.
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4.1.5 Acetone soluble extract [ASE]
5gms of the air-dried powder of Delonix regia was macerated with 100ml of 
acetone in a stoppered flask, shaking frequently during the first 6 hours   and 
allowed  to  stand  for  18  hrs.  Thereafter  it  was  filtered  rapidly  taking 
precaution  against  the loss  of  solvent.  Evaporate  25 ml  of  the filtrate  to 
dryness in a tarred flat bottom shallow dish dried at 105oC, and weighed. 
Percentage acetone soluble extractive was calculated with reference to the 
air-dried plant.
4.1.6 Methanol Soluble Extractive. [MSE]
5gms of the air-dried powder of Delonix regia was macerated with 100ml of 
methanol in a stoppered flask, shaking frequently during the first 6 hours and 
allowed  to  stand  for  18  hrs.  Thereafter  it  was  filtered  rapidly  taking 
precaution against the loss of solvent. 
Evaporate 25 ml of the filtrate to dryness in a tarred flat bottom shallow dish 
dried at 105oC, and weighed.  Percentage methanol-soluble extractive was 
calculated with reference to the air-dried plant.
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4.1.7 Water Soluble Extractive. [WSE]
5gms of the dried powder of  Delonix regia  was added into 50ml of boiled 
water at 80oC in a stoppered flask.  It was shaken well and allowed to cool, 
filtered.   5ml  of  filtrate  was transferred to  a tarred evaporating dish,  the 
solvent was evaporated on a water bath, allow to dry for 30min.  Finally 
dried in an oven for 2 hrs at 100oC and residue was weighed.  Percentage of 
water-soluble extractives was calculated with reference to the air-dried crude 
drug.
Calculations(79): 
25 ml of extract gives = X gm of residue.
For 100ml of extract gives = 4 * X of residue.
5 gm of air dried drug gives 4  * X gm of residue,
Then 100gms of air-dried drug gives 20 * 4 * X gm of residue.
Therefore 100gms of air-dried drug gives 80 X  %
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Table:02   Extractive values of Delonix regia (Boj. ex. Hook.) Raf leaf 
S.No Extractives Determined extractive values (% w/w)
01 n-Hexane 02.938
02 Petroleum ether 40-60 04.935
03 Chloroform 03.732
04 Ethyl acetate 07.865
05 Acetone 05.681
06 Methanol 21.249
07 Water 47.80
4. 2. ASH VALUES
The ash of any material is composed of their non-volatile inorganic 
components.  Controlled incineration of crude drugs results in an ash residue 
consisting of an inorganic material (metallic salts and silica).  This value 
varies within fairly wide limits and is therefore an important parameter for 
the purpose of evaluation of crude drugs.  In certain drugs, the percentage 
variation of the weight of ash from sample to sample is very small and any 
marked difference indicates a change in quality.  Unwanted parts of drugs, 
sometimes, possess a character that will raise the ash value-for example, the 
sclerides in the unwanted pericarp of colocynth and the cork on liquorice, 
which is not required in the powder of the peeled drug.  More direct 
contamination, such as by sand or earth, is immediately detected by the ash 
value.  The ash  value can be determined by three different methods to 
measure the total ash, the acid insoluble ash and the water soluble ash.
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4.2.1 Total Ash
Weigh accurately a quantity of the powdered drug equivalent to 1 gm of the 
air dried drug in a tarred platinum silica dish and incinerate a temperature 
not exceeding 550oC until free from carbon, approximately for about 4hrs, 
cool and weigh. Calculate the percentage of ash with reference to the air-
dried drug.
 
4.2.2 Sulphated Ash
Heat a silica or platinum crucible to redness for 10minutes and allow cooling 
in a desicator and weigh.  Put 1gm of the substance accurately weighed into 
crucible and ignite gently at first.  Cool moisten the residue with 0.5ml of 
Sulphuric acid, heat at 550°C for about 4 hrs. Cool and weigh, calculate the 
percentage of ash with reference to the air-dried drug.
Table : 03       Ash  values of Delonix regia (Boj. ex Hook.) Raf. leaves
S.No Ash Percentage ash value (w/w)
01 Total ash 07.40
02 Sulphated ash 07.19
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05. PHYTO CHEMICAL INVESTIGATION  
A. Method of extraction
Fresh leaf of Delonix regia were collected shade dried at room temperature, 
pulverized and extracted with 95% ethanol in a soxhlet extractor. The extract 
was concentrated in a rotary flash evaporator. The residue was dried in a 
desicator over sodium sulphite 
Table: 04  
Percentage extractives & physical characteristics of alcoholic extract of 
Delonix regia (Boj. ex Hook.) Raf. 
S.NO EXTRACT
% DRY
WEIGHT
COLOUR ODOUR CONSISTENCY
01
Crude 
alcoholic
25.85
Dark 
green
Characteristic Sticky
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B. QUALITATIVE PHYTOCHEMICAL ANALYSIS (76, 79 –85): 
The qualitative chemical tests for various phytoconstituents were carried out 
using the leaf alcoholic extract of Delonix regia 
5. B. 1.  Test for ALKALOIDS 
i.  Mayer’s test : Alkaloids give cream 
colour precipitate with Mayer’s Reagent [Potassium mercuric iodide 
solution].
ii.  Dragondroff’s test : Alkaloids give 
reddish brown precipitate with Dragondroff’s reagent [Potassium bismuth 
iodide solution].
iii.  Wagner’s test : Alkaloids give a reddish brown precipitate with 
Wagner’s  reagent.    [Solution of iodine in potassium iodide].
iv.  Hager’s test : Alkaloids give yellow 
colour precipitate with Hager’s reagent[Saturated solution of Picric acid].
v.  Tannic acid test :Alkaloids give buff 
colour precipitate with 10% Tannic acid solution.
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5. B. 2. Test for GLYCOSIDES :
General test for the presence of Glycosides: 
Test A : Extract 200mg of the drug by warming in a test tube with 5ml of 
dilute(10%) sulfuric acid on a water bath at 100oC for 2min, centrifuge or 
filter, pipette off supernatant or filtrate.  Neutralize the acid extract with 5% 
solution of Sodium hydroxide (noting the volume of NaOH added).  Add 
0.1ml of Feghling’s solution A and then B until alkaline(test with pH paper) 
and heat on  a water bath for 2min.  Note the quantity of red precipitate 
formed and compare with that formed in Test B.
Test B: Extract 200mg of the drug using 5ml of water instead of sulfuric 
acid.  After boiling add volume of water equal to the volume of sodium 
hydroxide   used in the above test.  Add 0.1ml of Feghling’s solution A and 
B until alkaline (test with pH paper) and heat on water bath for 2min.  Note 
the quantity of red precipitate formed.
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Compare the quantity of precipitate formed in Test B with that of formed in 
Test A.  If the precipitate in Test A is greater than in Test B then Glycoside 
may be present.  Since Test B represents the amount of free reducing sugar 
already present in the crude drug, Whereas Test A represents free reducing 
sugar plus those related on acid hydrolysis of any Glycosides in the crude 
drug.
5. B. 2.1. General tests for free sugars:
      After complete removal of free sugars, the extract is hydrolyzed with 
mineral acid    
      and then tested for the glycone and aglycone moieties.
a. Raymond’s test:  Test solution when treated with dinitrobenzene in hot 
methanolic   alkalie, gives violet color.
b.  Legal’s test:  Treat the extract with pyridine and add alkaline sodium 
nitroprusside   solution, blood red color appears.
c. Bromine water test: Test solution when treated with bromine water gives 
yellow   precipitate.
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5. B. 2. 2. Chemical tests for specific glycosides:
5. B. 2. 2. A.  Test for SAPONIN GLYCOSIDES:
Froth Test: Place 1ml solution of drug in water in a semi-micro tube shake 
well   and note the stable froth.
Haemolysis  test:  Add 0.2ml  solution  of  saponin(prepared in  1% normal 
saline) to  0.2ml of V/V blood in normal saline and mix well, centrifuge and 
note the red supernatant compare with control tube containing 0.2ml of 10% 
blood in normal saline diluted with 0.2ml of normal saline.
5. B.  2.  2.  B.  Test  for  ANTHRAQUINONE 
GLYCOSIDES:
Borntragers test:  Boil test material with 1ml of dil.sulphuric acid in a test 
tube for 5min (anthracene glycosides are hydrolyzed to aglycone and sugars 
by boiling with acids) centrifuge or filter while hot (if centrifuged hot, the 
plant  material  can  be  removed  while  anthracene  aglycone  are  still 
sufficiently soluble in hot water, they are however insoluble in cold water), 
pipette out the supernatant or filterate, cool and shake with an equal volume 
of dichloromethane (the aglycone will dissolve preferably in 
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dichloromethane) separate the lower  dichloromethane layer and shake with 
half its volume with dilute ammonia.  A rose pink to red color is produced in 
the ammoniacal layer (aglycones based on anthroquinones give red color in 
the presence of alkali).
Modified Borntragers test:  Boil 200mg  of the test material with 2ml of 
dilute sulphuric acid, 2ml of 5% aqueous ferric chloride solution for 5min 
and continue the test as above.  As some plant contains anthracene aglycone 
in a reduced form, if ferric chloride is used during the extraction, oxidation 
to anthroquinones takes place,  which shows response  to  the Borntrager’s 
test.
5. B. 2. 2. C. Test for CARDIAC GLYCOSIDES:
Kedde’s test:  Extract the drug with chloroform, evaporate to dryness, add 
one drop of 90% alcohol and 2 drops of 2% 3,5-dinitro benzoic acid(3,5-
dinitro benzene carboxylic acid-Kedde’s reagent)  in 90% alcohol.   Make 
alkaline with 20% sodium hydroxide solution. A purple color is produced. 
The color reaction with 3,5- dinitrobenzoic acid depends upon the presence 
of an α,β  -unsaturated-δ  lactones in the aglycone.
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Keller  killiani  test[test  for  Deoxy  sugars]:   Extract  the   drug  with 
chloroform and evaporate it to dryness.  Add 0.4ml of glacial acetic acid 
containing a trace amount of ferric chloride.  Transfer to a small test tube; 
add carefully 0.5ml of  concentrated sulphuric acid by the side of the test 
tube, blue color appears in the acetic acid layer.
5. B. 2. 2. D. Test for CYANOGENETIC GLYCOSIDES:
Place 200mg of drug in a conical flask and moisten with few drops of water, 
there should be no free liquid at the bottom of the flask (the test will not 
work if there is any liquid in the flask as the hydrogen cyanide produced will 
dissolve in the water rather than, come off as a gas to react with the paper). 
Moisten a piece of picric acid paper with sodium carbonate solution (5% 
aqueous) and suspended by means of cork in the neck of the flask, warm 
gently at about 37oC.  Observe the change in color.  Hydrogen cyanide is 
liberated  from cyanogenetic  glycoside  by the  enzyme  activity  and reacts 
with sodium picrate to form the reddish purple sodium isopicrate.
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5.B.3. Test for PHENOLIC COMPOUNDS (TANNINS, FLAVONOIDS 
& OTHER    PHENOLS)
Due to presence of vicinyl oxygenated function many of the compounds acts 
as legend for metal ions.  Thus ferric ions when added to solution of phenols 
produce dark green, blue or blue-black complex.  
5. B. 3. 1. Test for TANNINS:
01. Gelatin test:  Test solution with 1% gelatin solution containing 10% 
sodium chloride gives white precipitate.
02. Ferric chloride test:   Test solution give blue green color with Ferric 
chloride.
03.  Vanillin  Hydrochloride  test:   Test  solution  when  treated  with  few 
drops of Vanillin  Hydrochloride reagent gives purplish red color.
04. Tannins get  precipitated in the solution when treated with     heavy 
metals.
05.Tannins yield bulky precipitate with phenazone specially in the presence 
of sodium  and phosphate.
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06. Alkaline reagent test:  Test solution with sodium hydroxide solution 
gives yellow to   red precipitate within short time.
07. Metchell’s test:  With iron and ammonium citrate or iron and Sodium 
tartarate  Tannins  give  a  water-soluble  iron-tannin  complex  which  is 
insoluble in solution of  Ammonium acetate.
5. B. 3. 2. Test for FLAVONOIDS:
Shinoda  test  (Magnesium  Hydrochloride  reduction  test):  To the  test 
solution    add  few   fragments  of  Magnesium  ribbon  and  add  conc. 
Hydrochloric acid drop wise, pink scarlet, crimson red or  occasionally green 
to blue color appears after few minutes.
Zinc Hydrochloride reduction test:  To the test solution add a mixture of 
Zinc dust and conc. Hydrochloric acid.  It gives red color after few minutes.
Alkaline  reagent  test:  To  the  test  solution  add  few  drops  of  sodium 
hydroxide  solution;  formation  of  an  intense  yellow color  which  turns  to 
colorless  on  addition  of  few  drops  of  dil.acid  indicates  presence  of 
Flavonoids.
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5. B. 4. Test for PROTEINS & AMINOACIDS:
Millons test:  Test solution with 2ml of Millons reagent (Mercuric 
nitrate in nitric acid    containing traces of nitrous acid), white precipitate appears, which 
turns red upon gentle heating.
Ninhydrin test:  Amino acids and Proteins when boiled with 0.2% solution 
of Ninhydrin (Indane 1,2,3 trione hydrate), Violet color appears.
5. B. 5. Test for STEROLS & TRITERPENOIDS:   
Libermann-Buchard  test:   Extract  treated  with  few  drops  of  acetic 
anhydride, boil and  cool, conc. Sulfuric acid is added from the sides of  the 
test tube, shows a brown ring at the  junction of two layers and the  upper 
layer turns green which shows the presence of Steroids and formation of 
deep red color indicates the presence of triterpenoids.
Salkowski  test:   Treat  extract  in  Chloroform  with  few  drops  of  conc. 
Sulfuric acid, shake well and allow to stand for some time, red color appears 
at the lower layer indicates the    presence of Steroids and formation of 
yellow colored lower layer indicates the presence of Triterpenoids.   
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5. B. 6. Test for CARBOHYDRATES:
Molisch’s test:  Treat the test solution with few drops of alcoholic   alpha 
napthol.  Add 0.2ml of conc. Sulfuric acid slowly through the sides of the 
test tube, a  purple to violet color ring appears at the   junction.
Benedict’s test:  Treat the test solution with few drops of Benedict’s reagent 
(alkaline solution containing cupric citrate complex)  and upon boiling on 
water bath, reddish brown precipitate forms if reducing sugars are present.
Barfoed’s test:  It is a general test for Mono-saccharides.  Heat the test tube 
containing   1ml of reagent and 1ml of solution of compound in a beaker of 
boiling water; if red cuprous oxide is formed within 2min, mono-saccharides 
is present.  Disaccharide on prolonged heating(about 10min) may also cause 
reduction, owing to partial hydrolysis to mono-saccharides.
 Caramelisation:   Carbohydrates when treated with strong sulfuric  acid, 
they undergo charring with the dehydration along with burning sugar smell.
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Selwinoff’s  test:   Hydrochloric  acid  reacts  with  ketose  sugar  to  form 
derivatives  of  furfuraldehyde,  which  gives  red  colored  compound  when 
linked with resorcinol.  Add compound solution to about 5ml of reagent and 
boil.  Fructose give red color within half minute.  The test is sensitive to 
5.5mmol/ltr if glucose is absent, but if glucose is present it is less sensitive 
and in addition of large amount of glucose can give similar color. 
Tollen’s test:  To 100mg of compound add 2ml of Tollen’s reagent and heat 
gently, a silver mirror is obtained inside the wall of the test tube, indicates 
the presence of aldose sugar.
Bromine  water  test:  It  gets  decolorized  by  aldose  but  not  by  ketoses 
because bromine water oxidizes selectively the aldehyde group to carboxylic 
group, giving raise to general class of compounds called aldonic acid.
Fehling’s test:  Equal volume of Fehling’s A (Copper sulfate in distilled 
water)  and  Fehling’s  B  (Potassium  tartarate  and  Sodium  hydroxide  in 
distilled water) reagents are mixed and few drops of sample is added and 
boiled, a brick red precipitate of cuprous oxide forms, if reducing sugars are 
present.
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5. B. 7.  Test for FATS & FIXED OILS: 
Stain test: Press the small quantity of extract between two filter papers, the 
stain on  filter paper indicates the presence of fixed oils.
Saponification  test:   Add  a  few  drops  of  0.5N  of  alcoholic  potassium 
hydroxide  to  small  quantities  of  various  extracts  along  with  a  drop  of 
Phenolphthalein  separately  and  heat  on  a  water  bath  for  1-2hrs.   The 
formation of soap or partial neutralization of alkali indicates the presence of 
Fixed oils and Fats.
5. B. 8.  Test for VIT. C:
Sodium nitroprusside test:  When test solution is treated with sodium  - 
nitroprusside  solution, a blue color is produced.
Sodium bicarbonate test:  When test  solution  is  treated with sodium - 
bicarbonte solution,  a violet color is produced.
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Table: 05  Qualitative chemical examination of leaf alcoholic extract of 
Delonix regia (Boj. ex Hook.) Raf.
S.No PHYTOCONSTITUENTS ALCOHOLIC EXTRACT
01 ALKALOIDS Present
02 FLAVONOIDS Present
03 GLYCOSIDES Present
04 CARBOHYDRATES Present
05 PROTEINS   &AMINO ACIDS Present
06 VIT.C Nil
07 TANNINS Present
08 STEROLS Present
09 TRITERPENOIDS Present
10 SAPONINS Nil
06. TLC PROFILES FOR VARIOUS PHYTOCONSTITUENTS:
06. 1. TLC Profile Of Alkaloids(86)
Stationary phase : Silica Gel GF254
Mobile phase : Toluene (7): Ethyl acetate (2) : Diethyl amine (1)
Sample : Alcoholic extract.
Solvent front : 14.5 cm.
Detecting agent : UV detector for TLC at 365nm.
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Table: 06          TLC Profile of Alkaloids
Spot 
No
Visible Detection
(Colour of  the 
Spot)
UV365 Detection
(Colour of the 
spot)
Distance 
traveled
(Cm)
Rf
01 --- Pale green 1.5 0.10
02 --- Pale yellow 1.9 0.13
03 Light Yellow Dark Blue 5.0 0.35
04 Dark Yellow Dark Blue 6.2 0.43
05 Dark Green Pink 8.0 0.55
06 Light Green Pink 8.6 0.59
06. 2. TLC Profile Of Flavanoids(86)
Stationary phase : Silica Gel GF254
Mobile phase : Toluene (8) : Ethyl acetate (2)
Sample : Alcoholic extract.
Solvent front : 14.0 Cm
Detecting agent : UV detector for TLC at 365nm.
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Table: 07          TLC Profile of Flavanoids
Spot 
No
Visible Detection
(Colour of  the 
Spot)
UV365 Detection
(Colour of the 
spot)
Distance 
traveled
(Cm)
Rf
01 --- Light Rose 8.2 0.59
02 Light Yellow Pink 9.0 0.64
03 Green Dark Rose 9.2 0.66
04 Green Dark Rose 9.4 0.67
05 Light Yellow Pink 9.6 0.69
06 Grey Pink 10.0 0.71
07 Light Yellow Rose 11.0 0.79
08 Green Dark Pink 11.2 0.80
06. 3. TLC Profile Of Glycosides(86)
Stationary phase : Silica Gel GF254
Mobile phase : Ethyl acetate (81) : Ethanol (11) : Water (08)
Sample : Alcoholic extract.
Solvent front : 15.0 cm.
Detecting agent : UV detector for TLC at 365nm.
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Table: 08          TLC Profile of Glycosides
Spot 
No
Visible Detection
(Colour of  the 
Spot)
UV365 Detection
(Colour of the 
spot)
Distance 
traveled
(cm)
Rf
01 --- Violet 1.0 0.07
02 --- Violet 6.0 0.40
03 Dark Brown Pale yellow 6.3 0.42
04 --- Violet 10.0 0.67
05 Light Brown Pale green 11.0 0.73
06 Light Yellow Brown 12.2 0.81
07 Green Pale yellow 13.8 0.92
08 --- Pink 14.8 0.98
06. 4. TLC Profile Of Sterols(87)
Stationary phase : Silica Gel GF254
Mobile phase :  Chloroform (97)  :  Diethyl  ether  (2.3)  :  Acetic 
acid (0.3)
Sample : Alcoholic extract.
Solvent front : 16.4 cm.
Detecting agent : UV detector for TLC at 365nm.
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Table: 09          TLC Profile of Sterols
Spot 
No
Visible Detection
(Colour of the 
Spot)
UV365 Detection
(Colour of the 
spot)
Distance 
traveled
(Cm)
Rf
01 Light Green Violet 03.6 0.22
02 Dark Green Red 03.9 0.24
03 Light Green Pink 04.3 0.26
04 --- Pink 04.5 0.27
05 --- Pink 06.2 0.38
06 --- Pink 06.4 0.39
07 --- Violet 09.1 0.56
08 --- Green 12.0 0.73
09 --- Pale Green 13.5 0.82
07. ISOLATION OF PHYTOCONSTITUENTS:
07.1.  Isolation  of  sterols  from  Delonix  regia (Boj.  ex  Hook.)  Raf. 
leaves(81&88):
100gms  of  the  air-dried  plant  material  was  exhaustively  extracted  using 
500ml of Petroleum ether (40 – 60°) in a soxhlet extractor. The solvent was 
removed under vacuum in a rotary flash evaporator,  which leaves a dark 
green waxy residue. The residue was taken and saponified with alcoholic 
potassium hydroxide  (30gms  of  potassium hydroxide  was  dissolved  in  a 
minimum quantity of water and the volume was made up to 750ml with 
alcohol. Allowed to stand over night and the clear supernatant liquid was 
used) for an hour.  Saponified material was then transferred to a separator 
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and the contents of the flask were washed with about 100 ml of water and 
run  in  the  separator,  contents  of  the  separator  were  then  extracted  with 
successive quantities of petroleum ether 30ml each for 4 times (30 × 4).  The 
ethereal solution was then transferred to a second separator containing 75ml 
of distilled water, the contents were shaken gently and the aqueous layer was 
run off.  The ethereal solution was then washed by shaking with 
successive quantities of distilled water (50 × 3).  The petroleum ether layer 
was extracted with 25ml of 0.5N aqueous potassium hydroxide (25 × 2), 
shaking vigorously in each extraction, later the petroleum ether layer was 
shaken washed with 25ml of distilled water till the aqueous layer was no 
longer alkaline to phenolphthalein.
The  petroleum  ether  was  recovered  under  vacuum  in  a  rotary  flash 
evaporator.  This  is  kept  overnight  in  refrigerator  yields  an  amorphous 
powder of unknown crude sterols which were named as S1, the S1 sterols are 
removed  by filtration and the pale  greenish yellow residue  obtained was 
shaken  with  small  quantity  of  acetone  and  filtered.  The  filtrate  was  left 
overnight in a evaporating dish, an amorphous powder of sterols formed at 
the base of the dish. This is named as S2.
The percentage yield of sterols obtained was 6.0 %w/w.
a. The percentage yield of  S1 sterols was: 1.8% w/w
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b. The percentage yield of S2 sterols was:  4.2 % w/w
The  isolated  sterols  were  subjected  to  phytochemical  test  to  detect  the 
presence of sterols.
07.1.1.    Phytochemical tests for Isolated Sterols:
A. Libermann-Buchard test:  Isolated compounds are treated with few 
drops of acetic anhydride, boil and  cool, conc. Sulfuric acid is added from 
the sides of  the test tube,  shows a brown ring at the  junction of two layers 
and the  upper layer turns green which shows the presence of Sterols. 
B.Salkowski test:  Isolated products were treated with chloroform and few 
drops of conc. Sulfuric acid, shake well and allow to stand for some time, 
red color appears at the lower layer indicates the    presence of Steroids.
07.1.2.  TLC Profile Of Isolated Crude Sterols(87)
Stationary phase : Silica Gel GF254
Mobile phase :  Chloroform (97)  :  Diethyl  ether  (2.3)  :  Acetic 
acid (0.3)
Sample : Isolated sterols.
Solvent front : 13.8 cm.
Detecting agent : UV detector for TLC at 365nm.
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Table: 10          TLC Profile of Isolated Crude Sterols
Spot 
No
Visible Detection
(Colour of the 
Spot)
UV365 Detection
(Colour of the 
spot)
Distance 
traveled
(Cm)
Rf
01 Light Green Violet 03.2 0.23
02 Dark Green Red 03.4 0.24
03 Light Green Pink 03.6 0.26
04 --- Pink 05.4 0.39
05 --- Violet 07.7 0.56
06 --- Green 10.1 0.73
7. 2.  CHROMATOGRAPHY(89&90)
Chromatography is essentially a technique for the separation of the 
components of mixtures by a continuous distribution of the components 
between two phases, one of which is moving past the other.  The systems 
associated with this definition are:
a. A solid stationary phase with a liquid or gaseous mobile phase and 
b. A liquid stationary phase with a liquid or gaseous mobile phase;  the 
former
1. Gives rise to adsorption chromatography and the latter
2. To partition chromatography.
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The theoretical treatment of these divisions gives results which are not 
entirely satisfactory and the experimental procedure are diverse. The latter 
however, have followed from the development of chromatography from its 
early days and it is convenient to consider the procedures separately.
7.2.1. Column Chromatography
The technique was originally developed by the Russian botanist Tswett in 
1906 during the course of an investigation into the nature of leaf pigments. 
He found that leaf pigments extracted with light petroleum were adsorbed on 
the top of a column of calcium carbonate supported in a glass tube.  As more 
solvent was allowed to percolate through the column the region of 
pigmentation became broader and finally separated into distinct and 
differently  coloured bands.  Prolonged washing with solvent caused 
complete separation of the bands which could be eluted separately.  It is one 
of the simplest laboratory exercises to illustrate the use of column 
chromatography.
The principle underlying the separation of the components is adsorption at 
the solid liquid interface.  For successful separation, the compounds of a 
mixture  must show different degrees of affinity for the solid  support (or 
adsorbent) and the interaction  between adsorbent and component must be 
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reversible.  As the adsorbent is washed with fresh solvent the various 
components  will therefore moved down the column until, ultimately, they 
are arranged  in order of their  affinity for the adsorbent.  Those with least 
affinity move down the column at a faster rate than those with greater 
affinity for the adsorbent.
An adsorbent which is already saturated with respect  to one substance may 
take up a small quantity of a second.  The latter displaces the former and 
consequently if a solution of a mixture is percolated continuously through 
the column and the elute is examined for the presence of substances.
7.2.2. Preparation of column
Prepare the chromatographic column by mixing the adsorbent into a slurry 
with the solvent and pouring the mixture into the glass tube which contain 
the solvent.  The filtering aid serves to give a flat base to column of 
adsorbent.  After the adsorbent has settled, add a filter paper disc and cotton 
then run of the supernatant liquid until the level falls to about 1cm above the 
top layer of cotton.  The filter paper disc and cotton is one means of 
avoiding  disturbances of the adsorbent as fresh mobile phase is added to the 
column  in the initial stages of development. The level of solvent must never 
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be allowed to fall below the level of adsorbent, otherwise the latter develops 
cracks and becomes useless for chromatography because the solvent runs 
through the cracks rather than between the particles of adsorbent.
The preparation of slurry may prove difficult with dense adsorbents and it is 
convenient to pour the powder directly into the solvent in the tube.  Frequent 
tapping of the tube and stirring of the mixture assists in even packing and 
removal of air bubbles or pockets.  Alternatively, the tube may be packed 
with the dry powder and the solvent allowed to percolated through with the 
stopcock open until the level falls to about 1 cm above the adsorbent.
The dimension of the column and quantity of adsorbent depend upon the 
nature and amount of the substance to be chromatographed.
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Table:  11                 Adsorbents and Solvents 
S.No Nature Adsorbent Solvents
01 Weak Sucrose
Starch
Inulin
Talc
Sodium carbonate
Petroleum ether
Carbon tetrachloride
Cyclohexane
Carbondisulphide
Ether (ethanol free)
Acetone
Benzene
Toluene
Esters
Chloroform
Alcohols 
Water
Pyridine
Organic acids
02 Mediu
m
 Calcium carbonate
Calcium phosphate
Magnesium carbonate
Magnesium oxide
Calcium hydroxide
03 Strong Activated magnesium 
silicate
Activated alumina
Activated charcoal
Activated magnesia
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Fullers earth Mixture of acids or bases 
with ethanol or pyridine
04 Neutral Silica gel 
Table: 12        Column characteristics
01 Adsorbent/adsorbate weight ratio 30:01
02 Length/diameter ratio 10-15:01
03 Column length
(a) Multi component system
(b)Components with similar affinities for 
adsorbent
(c) Components with different affinities for 
adsorbent
Long column
Long column
Short column
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Note: 
* The 30:01 ratio is suitable for preparative separations. For analytical 
purposes the ratio (30:01) is much too small and often mg quantities of 
substances are chromatographed on 20g or more adsorbent
* In general , narrow columns give better separations than wide columns.
7.2.3. Use of Column
Wash the column with about 50ml of the  mobile phase used to prepare it, 
which should be the least polar solvent in which the mixture will dissolve. 
Add the  mixture dissolved in  a small volume of  solvent and carefully 
allow it run into the filter aid layer by opening the stopcock.  Add a small 
volume of solvent and wash in the mixture.  Repeat with gradually 
increasing quantities of solvent and develop the chromatogram, collecting 
the eluate in appropriate receivers if the components are to be eluted from 
the column.
7.2.4. Detection and Recovery of Components
For those mixtures which are coloured visual examination of the column is 
usually sufficient to locate the coloured components.  Colourless 
components may also be detected visually if they fluoresce, e.g. Quinine and 
Ergometrine.  Recovery of the components after detection on the column 
236
requires extrusion of the column of adsorbent and isolation of each zone for 
extraction with solvents.  If plastic tubing is used instead of glass tubes the 
zones are conveniently isolated by cutting the tubing into sections.
It is however, more convenient to complete the chromatogram by eluting the 
various components with solvents.  For colourless compounds the eluate is 
collected as a large number of fractions, each of small volume.
The advent of automatic fraction collectors has enabled large numbers of 
fractions to be obtained without the tedium associated with manual 
collection.  The large number of fractions also assists in obtaining better 
separation of components providing attention is directed to correct choice of 
flow rate. 
Each fraction is examined appropriately for the presence of a compound. 
The examination may be by evaporation of the solvent from each fraction 
and weighing the residue, by simple spot tests, by examination of the 
fraction by paper or thin layer chromatography or by spectrophotometry, 
either directly or after addition of reagents.
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7.2.5. ISOLATION OF PHYTOCONSTIUENTS BY COLUMN 
CHROMATOGRAPHY
Length of the column : 60cm ( 2 feet)
Diameter : 2.5cm
Stationary phase : Silica gel for Column ( 60 –120 mesh size)
 Mobile phases: 
n-Hexane, Petroleum ether 60-80, chloroform, Ethyl acetate & Methanol.
Column Packing Method:    Wet packing
The adsorbent silica gel is made into a slurry with n-Hexane and poured 
inside the column and the adsorbent is allowed to settle down. The column is 
packed by this method for about a length of 30-40 cm.  
Sample preparation:
About 15gms of the leaf alcoholic extract is taken and dissolved in hexane 
and slurred with silica gel 60 – 120 and it was transferred into the column.
The contents were then covered by means of cotton plugging.
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Elution rate : 01 drop/sec
The contents of the column were then eluted using organic solvents of 
following proportions:
Table: 13        Column Chromatography for phytoconstituents isolation
S.No Mobile Phase
Proportion
           %
Quantity 
utilized
Number of fractions 
collected
01 N -Hexane 100 300ml 01 – 15
02
N-Hexane : 
Petroleum ether 
90:10 300ml 16 - 30
03
N – Hexane: 
Petroleum ether
80:20 300ml 31 – 40
04
N – Hexane: 
Petroleum ether 
70:30 300ml 41 – 50
05
N – Hexane : 
Petroleum ether
60:40 300ml 51 – 60
06
N – Hexane : 
Petroleum ether
50:50 300ml 61 – 70
07 Petroleum ether 100 300ml 71 – 82
08
Petroleum 
ether: 
Chloroform
90:10 300ml 83 – 93
09 Petroleum 
ether: 
80:20 300ml 94 – 104
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Chloroform
10
Petroleum 
ether: 
Chloroform
70:30 300ml 105 – 114
11
Petroleum 
ether: 
Chloroform
60:40 300ml 115 – 125
12
Petroleum 
ether: 
Chloroform
50:50 500ml 126 - 159
13 Chloroform 100 300ml 160 – 172
14
Chloroform: 
Ethyl acetate
90:10 300ml
173 – 185
15
Chloroform: 
Ethyl acetate
80:20 300ml 186 – 196
16
Chloroform: 
Ethyl acetate
70:30 300ml 197 – 207
17
Chloroform: 
Ethyl acetate
60:40 300ml 208 – 221
18
Chloroform: 
Ethyl acetate
50:50 300ml 222 – 234
19 Ethyl acetate 100 300ml 235 – 247
20
Ethyl acetate: 
Methanol
90:10 300ml 248 – 265
21
Ethyl acetate: 
Methanol
80:20 300ml 266 – 277
22 Ethyl acetate: 70:30 300ml 278 – 290
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Methanol
23
Ethyl acetate: 
Methanol
60:40 300ml 291 – 303
24
Ethyl acetate: 
Methanol
50:50 300ml 304 – 316
25 Methanol 100 400ml 317 - 335
After collection of each fraction, they  were subjected to TLC using Silica 
Gel GF 254 using the same mobile phase of their elution and observed under 
UV 254/365 and based upon the nature preliminary phytochemical tests and 
specified TLC profiles were carried out.
Table: 14         Detection  of  Phytoconstituents from various fractions
S.No Fractions Mobile Phase Number of 
Spots
01 01 – 15 N –Hexane 100% 03
02
16 - 30
N - Hexane 90%: Petroleum ether 
10%
02
03
31 – 40
N – Hexane 80%: Petroleum ether 
20%
01 (S3)
04
41 – 50
N – Hexane 70%: Petroleum ether 
30%
Nil
05
51 – 60
N – Hexane 60%: Petroleum ether 
40%
02
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06
61 – 70
N – Hexane 50%: Petroleum ether 
50%
01 (S4)
07 71 – 82 Petroleum ether 100% 01 (S4)
08
83 – 93
Petroleum ether 90%: Chloroform 
10%
Nil
09
94 – 104
Petroleum ether 80%:Chloroform 
20%
01 (S5)
10
105 – 114
Petroleum ether 70%:Chloroform 
30%
01 (S6)
11
115 – 125
Petroleum ether 60%:Chloroform 
40%
01 (S7)
12
126 - 159
Petroleum ether 50%: 
Chloroform50%
01 (S8)
13 160 – 172 Chloroform 100% 06
14 173 – 185 Chloroform 90% : Ethyl acetate 10% 06
15 186 – 196 Chloroform 80%: Ethyl acetate 20% 04
16 197 – 207 Chloroform 70%: Ethyl acetate 30% Nil
17 208 – 221 Chloroform 60%: Ethyl acetate 40% Nil
18 222 – 234 Chloroform 50%: Ethyl acetate 50% 04
19 235 – 247 Ethyl acetate 100% 03
20 248 – 265 Ethyl acetate 90%: Methanol 10% 01 (F1)
21 266 – 277 Ethyl acetate 80%: Methanol 20% Nil
22 278 – 290 Ethyl acetate 70%: Methanol 30% Nil
23 291 – 303 Ethyl acetate 60%: Methanol 40% Nil
24 304 – 316 Ethyl acetate 50%: Methanol 50% Nil
25 317 - 335 Methanol 100% Nil
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Identification of isolated phytoconstituents
01.   S3  .
Stationary Phase : Silica Gel GF254
Mobile Phase : n – Hexane (80) : Petroleum ether (20)
Detector : UV 254/365
Colour : Fluorescent Green
Rf : 0.50
Quantity collected : 14mg
Collection procedure: The fractions (31-40) which are shown the same Rf, 
colour with respect to a particular mobile phase with fixed proportions are 
pooled together and evaporated to dryness and collected.
02.   S4  .
Stationary Phase : Silica Gel GF254
Mobile Phase : n – Hexane (50) : Petroleum ether (50)
Detector : UV 254/365
Colour : Fluorescent Green
Rf : 0.40
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Quantity collected : 16mg
Collection procedure: The fractions (61-82) which are shown the same Rf, 
colour with respect to a particular mobile phase with fixed proportions are 
pooled together and evaporated to dryness and collected.
03.   S5  .
Stationary Phase : Silica Gel GF254
Mobile Phase : Petroleum ether (80) : Chloroform (20)
Detector : UV 254/365
Colour : Light Green
Rf : 0.45
Quantity collected : 26.2mg
Collection procedure: The fractions (94-104) which are shown the same Rf, 
colour with respect to a particular mobile phase with fixed proportions are 
pooled together and evaporated to dryness and collected.
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04.   S6  .
Stationary Phase : Silica Gel GF254
Mobile Phase : Petroleum ether (70) : Chloroform (30)
Detector : UV 254/365
Colour :  Fluorescent yellow
Rf : 0.75
Quantity collected : 07mg
Collection procedure: The fractions (105 – 114) which are shown the same 
Rf, colour with respect to a particular mobile phase with fixed proportions 
are pooled together and evaporated to dryness and collected.
05.   S7  .
Stationary Phase : Silica Gel GF254
Mobile Phase : Petroleum ether (60) : Chloroform (40)
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Detector : UV 254/365
Colour :  Yellow
Rf : 0.70
Quantity collected : 27mg
Collection procedure: The fractions (115-125) which are shown the same 
Rf, colour with respect to a particular mobile phase with fixed proportions 
are pooled together and evaporated to dryness and collected.
06.   S8  .
Stationary Phase : Silica Gel GF254
Mobile Phase : Petroleum ether (50) : Chloroform (50)
Detector : UV 254/365
Colour :  Fluorescent green
Rf : 0.34
Quantity collected : 473mg
Collection procedure: The fractions (126-159) which are shown the same 
Rf, colour with respect to a particular mobile phase with fixed proportions 
are pooled together and evaporated to dryness and collected.
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07.   F1  .
Stationary Phase : Silica Gel GF254
Mobile Phase : Ethyl acetate (9) : Methanol (1)
Detector : UV 254/365
Colour :  Green
Rf : 0.85
Quantity collected : 100mg
Collection procedure: The fractions (248-265) which are shown the same 
Rf, colour with respect to a particular mobile phase with fixed proportions 
are pooled together and evaporated to dryness and collected.
08.   S1  .
Stationary Phase : Silica Gel GF254
Mobile Phase : Chloroform (97): Diethyl ether(2.3) : Conc. 
Acetic acid (0.5)
Detector : UV 254/365
Colour :  Light rose
Rf : 0.25
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09.   S2  .
Stationary Phase : Silica Gel GF254
Mobile Phase : Chloroform (97): Diethyl ether(2.3) : Conc. 
Acetic acid (0.5)
Detector : UV 254/365
Colour :  Light rose, pink, Green and Flourescent yellow.
Rf : 0.25, 0.4, 0.6 & 0.88
Each isolated sterols  (S3 –S8)  were first subjected to preliminary 
phytochemical tests of  Libberman Buchard and Salkowski tests and further 
confirmed by means of  carrying out the specific TLC profiles for sterols 
using  Chloroform (97): Diethyl ether(2.3) : Conc. Acetic acid (0.5) as the 
mobile phase.
In the similar  way the isolated flavanoid  F1 was subjected to preliminary 
phytochemical tests of  Shinoda test (Magnesium Hydrochloride reduction 
test),  Zinc  Hydrochloride  reduction  test  and   Alkaline  reagent  tests  and 
further confirmed by means of carrying out the specific TLC profiles for 
flavanoids using Benzene (9) : Acetone (1) as the solvent system.
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PLAN OF THE WORK
 Collection, Authentication & Shade drying of Delonix regia (Boj. ex 
Hook.) Raf. leaves
 Coarse powdering of the air dried plant material.
 Extraction of the material using 95% ethanol.
 Preliminary phytochemical screening of plant extracts.
 Preliminary TLC studies of the plant extracts.
 Crude isolation of sterols.
 Isolation of phytoconstituents by Column chromatography.
 Confirmation of the isolated compounds by means of phytochemical 
and TLC studies.
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 Spectral elucidation of the isolated compounds through
► UV
► IR
► NMR
► GC-MS
 Determination of impurities present in  the isolated compound by 
HPLC technique.
 Structural elucidation of the isolated compounds.
 Evaluation of Anti-microbial potential of the crude extract.
 Determination of Anti-oxidant potential of isolated compounds by
 Estimation of Total phenolics as a preliminary measure of 
antioxidant potential.
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 In vitro models
► Reducing power ability
► DPPH radical scavenging assay
► Nitric Oxide radical scavenging assay.
 Ex vivo model
► Estimation of TBAR’s (Lipid peroxidation assay)
 Statistical analysis.
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ANALYTICAL STUDIES
Analytical  chemistry  deals  with  methods  for  determining  the  chemical 
composition of samples of matter.  A qualitative methods yields information 
about the identity of atomic or molecular species or the functional groups in 
the  sample.   A  quantitative  method  in  contrast  provides  numerical 
information as to the relative amount of one or more of these components.
In the early years of chemistry, most analyses were carried out by separating 
the  components  of  interest  in  a  sample  by  precipitation,  extraction  or 
distillation.  Early in the 20th century, chemists began to exploit phenomenon 
other than those used for classical methods for solving analytical problems. 
Thus measurements of physical properties of analytes such as conductivity, 
electrode potential, light absorption or emission, mass to charge ratio and 
fluorescence  began  to  be  used  for  quantitative  analysis  of  variety  of 
inorganic, organic and biochemical analytes.
Furthermore, highly efficient chromatographic and electrophoretic technique 
began to replace distillation, extraction and precipitation for the separation 
of components of complex mixtures prior to their qualitative or quantet 
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determination.   These  newer  methods  for  separating  and  determining 
chemical species are known collectively as instrumental methods of analysis 
has paralleled the development of the electronic and computer industries.
1. FLAME EMISSION SPECTROSCOPY(91&92)
The absorption and emission of radiant energy by atoms provide powerful 
analytical tools for both quantitative and qualitative analysis.   Most 
recently, new sources for plasma emission spectroscopy offer capabilities 
this complement Flame Emission Spectroscopy and Atomic Absorption 
Spectroscopy for many analysis.
Flame photometry is also named as FLAME EMISSION SPECTROSCOPY 
because of the use of a flame to provide the energy of excitation to atoms 
introduced into the flame.
Flame photometry  is  based  on the  measurement  of  intensity  of  the light 
emitted when a metal  is introduced into a flame.  The wavelength of the 
colour tells us what the element is and the colours intensity tells us how 
much of the element is present.
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The instrument permitted us to select the wavelength of the radiation and 
measure  its  intensity  with  considerable  accuracy.   The  spectrophotmetric 
technique has proven to be one of most reliable and easily used techniques 
for the determination of concentration of sodium, potassium, calcium and 
magnesium.
Flame  photometry  coupled  with  simple  read-out  devices,  provides  high 
sensitivity and high reliability for the determination of elements in the first 
two  columns  of  the  periodic  table.   Among  these  elements  are  sodium, 
potassium,  lithium,  calcium,  magnesium,  strontium  and  barium.   The 
measurement of these elements is very useful in medicine, agriculture and 
plant science.  Flame photometry is also successful in determining certain 
transition elements such as copper, iron and manganese.
Flame photometry is a simple, rapid method fro the routine determination of 
elements that can be easily excited.
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1.1. Applications
* The most useful application of flame photometry is for the rapid 
quantitative determination of the elements in the group I and II of the 
periodic table, using equipment with high optical resolution; other metallic 
elements may also be determined.
*  The  principal  analytical  advantages  of  flame  photometry  include  its 
simplicity and speed.
* Flame photometry gives no information on molecular analysis, but it is 
used widely for elemental analysis.
1.2. Determination of Na+, K+ and Ca2+ in Delonix regia leaves
This determination is based on a flame photometry method utilizing atomic 
absorption  (AA).  The  liquid  sample  containing  sodium,  potassium  and 
calcium ions is aspirated into a very well-defined and shaped flame. The 
ions are reduced in the flame to atoms. Light from a lamp passes through the 
flame and is absorbed specifically by the selected atoms in the flame. With a 
constant aspiration rate (flow), and consistent formation of sample aerosol 
droplets in the flame, the concentration of Na+, K+ and Ca2+ atoms in the 
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flame is proportional to the concentration in the liquid sample. Absorption of 
the light from the lamp by the selected atoms in the flame follows Beer's 
Law.  The  instrument  obtains  the  flame  absorbance  of  a  sample  by 
comparing the transmittance (P) with that of a blank solution (Po).
A = log[Po/P] = abC(unk)
The method  used to obtain the ionic  concentration is the standard addition 
approach used with solution photometry. 
1.2.1. Preparation of Solutions 
Results of the solution photometry experiment should provide an idea of the 
ions concentration. Convert the concentration to ppm of Na+, K+ and Ca2+. 
Stock solution:
* Sodium = 50 mEq/L (as Na+ )
Dissolve 2.923 gm of NaCl in one litre of distilled water.
* Potassium  = 50 mEq/L (as K+ )
Dissolve 3.728 gm of KCl in one litre of distilled water.
* Calcium = 50 mEq/L (as Ca2+ )
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Dissolve 2.503 gm of CaCO3 in approximately 300ml of distilled water and 
10ml of Conc.Hcl, Dilute to one litre with water.
Dilutions
* For Na+
0.5ml to 100ml, which is equivalent to 1 mEq.
1.0ml to 100ml, which is equivalent to 2 mEq.
2.0ml to 100ml, which is equivalent to 4 mEq.
* For  K+
1.0 ml to 100ml, which is equivalent to 0.1 mEq.
10 ml to 100ml, which is equivalent to 1.0 mEq.
20ml to 100ml, which is equivalent to 2.0 mEq.
* For  Ca2+
5.0ml to 100ml, which is equivalent to 2.5 mEq.
10ml to 100ml, which is equivalent to 5.0 mEq.
20ml to 100ml, which is equivalent to 10 mEq.
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1.2.2. Sample preparation:
One gm of the powdered drug is taken and total ash of the same is determined using muffle furnace.  The 
yield of total ash was found to be 07.3967%.  The obtained ash is chopped  with 5% Hydrochloric acid  
(100ml).  The contents were mixed properly and filtered. The filtrate is taken and made up to 100ml with  
water.  The sample is taken for elemental analysis.
1.2.3. Procedure
The flame photometer is calibrated for  Na+, K+ and Ca2+ ions separately 
using the diluted stock solutions. After the calibration of the instrument the 
prepared sample is taken for analysis separately for each ions.
The blank solution used for the AA measurements can be simply deionized 
water.
The obtained mEq values are converted to ppm by multiplying the value 
with molecular weight of the substance.
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Table: 15        Content of Na+, K+ and Ca2+ in  Delonix regia  (Boj. ex 
Hook.)  leaves
S.No Ions mEq ppm
01 Sodium (Na+) 0.5 11.4949
02 Potassium (K+) 0.1 03.9098
03 Calcium (Ca2+) 1.0 10.0800
2. SPECTROMETRIC METHODS(93-99)
These are of 3 types:
a. Molecular spectrometry
b. Mass spectrometry
c. X-ray spectrometry
2.1. Molecular spectrometry
The molecular spectrometry comprises of UV/Visible, IR and NMR 
spectroscopy.  In which the UV is based upon absorption, IR on Vibration 
and NMR by means of Spinning.
2.2. Mass spectrometry
In atomic mass spectrometry, samples are also atomized, but in this case, the 
gaseous atoms are converted to positive ions (usually single charged) and 
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separated on the basis of their mass to charge ratios.  Quantitative data are 
then obtained by counting the separated ions.
2.3. X-ray spectrometry
Atomization is not required because X-ray spectra for most elements are largely 
independent of how they are chemically combined in sample.
3. 0  Spectroscopy: 
3.1. ULTRA VIOLET AND VISIBLE SPECTROSCOPY
3.1.1. Principle:
When UV or visible radiation is passed through a substance under 
examination, absorption of energy results in the promotion of electron from 
the ground electronic state to the excited electronic state.  During the process 
of absorption, a large number of photon-molecule collisions are possible but 
only those collisions will cause absorption of energy in which the energy of 
photon matches the energy difference between the ground and excited 
electronic state of the molecule.  The absorption of energy is quantised.  In 
UV and Visible spectroscopy, electronic transition takes place.
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 UV is the electronic spectroscopy since it involves the promotion of 
electrons (σ, pi, n* electrons) from the ground state to the higher energy 
state.
 It is very useful to measure the number of conjugated double bonds 
and also aromatic conjugation within the various molecule.
 It also distinguish between conjugated and non conjugated system 
α,β- unsaturated carbonyl compounds from β , γ  analogues, homo 
annular, hetero annular conjugated dienes etc.,
 For visible and UV spectrum, electronic excitations occur in 200-800 
nm and involves the promotion of  electrons to the higher energy 
molecular orbital.
 There are two laws with govern the absorption of light by the 
molecules. These are Lambert’s law and Beers law.
 Ultra-Violet spectroscopy has been mainly applied for the detection of 
functional group (Chromophore), the extent of conjugation, detection 
of polynuclear compounds by comparison.
 Electronic spectroscopy : UV 200-400 nm.
            Visible 400 – 800 nm.
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3.2. INFRA RED SPECTROSCOPY
Infra red spectrum is an important about the structure of a compound.  This 
technique provides a spectrum containing a large number of absorption 
bands from which a wealth of information can be derived about the structure 
of an organic compound.
The IR region of the spectrum encompasses radiation with wave numbers 
ranging from about 12,800 – 10 Cm-1 or wave length from 0.78 to 1000µm. 
From the stand point of both application and instrumentation, the IR 
spectrum is conveniently divided into near, mid and far Infra Red radiation 
(Rough limitations of ).
The technique can be employed to establish the identity of two compounds 
or to determine the structure of a new compound.  Its quite useful to predict 
the presence of certain fundamental groups which absorps at definite 
frequencies, for example the hydroxyl group in a compound absorps at 3600 
– 3200 Cm-1 , carbonyl group of  ketone groups give a strong band at 1710 
Cm-1 . It is thus a  reliable technique for disclosing the identity of a 
compound.  
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* It has been found that, no two compounds except the enantiomers can have 
similar Infra-red spectra.
The IR spectrum of a compound provide  more information than is normally 
available from the electronic spectra.
In this technique, almost all groups absorb characteristically with in  a 
definite range.  The shift in the position of absorbing for a particular group 
may change with the changes in the structure of the molecule.
Impurities in a compound can be detected from the nature of the bands, 
which no longer remain and well defined. Example, if the spectrum contains 
a strong absorption band between 1,900 – 1,600 Cm-1  the presence of 
carbonyl group (-C=O) in a compound is suspected.
The position of the peak or the band not only tells the presence of a 
particular group but also reveals a good deal about the environment affecting 
the group.
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3.3. NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY
NMR spectroscopy has become a powerful  tool  for  the organic  chemist. 
This  technique  is  only  applicable  to  those  nuclei  which  possess  a  spin 
quantum  number  greater  than  zero.   The  two  types  of  spectra  most 
frequently encountered by the organic chemist are 1H and 13C NMR spectra.
3.3.1. Proton NMR Spectroscopy
This  important  and  well-established  application  of  nuclear  magnetic 
resonance will serve to illustrate some of the novel aspects of this method. 
To begin with, the NMR spectrometer must be tuned to a specific nucleus, in 
this case the proton. The actual procedure for obtaining the spectrum varies, 
but  the  simplest  is  referred  to  as  the  continuous wave (CW) method.  A 
solution of the sample in a uniform 5 mm glass tube is oriented between the 
poles  of  a  powerful  magnet,  and  is  spun  to  average  any  magnetic  field 
variations,  as  well  as  tube  imperfections.  Radio  frequency  radiation  of 
appropriate  energy  is  broadcast  into  the  sample  from  an  antenna  coil 
(colored red). A receiver coil surrounds the sample tube, and emission of 
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absorbed  rf  energy  is  monitored  by  dedicated  electronic  devices  and  a 
computer. 
An NMR spectrum is acquired by varying or sweeping the magnetic field 
over a small range while observing the rf signal from the sample. An equally 
effective technique is to vary the frequency of the rf radiation while holding 
the external field constant. For example Proton NMR spectra of camphor is
3.3.2. 1H NMR OF CAMPHOR
Spectra: 01
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3. 3. 3. Carbon NMR Spectroscopy
The power and usefulness of 1H NMR spectroscopy as a tool for structural 
analysis should be evident from the past  discussion.  Unfortunately,  when 
significant  portions  of  a  molecule  lack  C-H  bonds,  no  information  is 
forthcoming. 
Even  when  numerous  C-H  groups  are  present,  an  unambiguous 
interpretation of a proton NMR spectrum may not be possible. 
These  difficulties  would  be  largely  resolved  if  the  carbon  atoms  of  a 
molecule  could be probed by NMR in the same fashion as the hydrogen 
atoms. Since the major isotope of carbon (12C) has no spin, this option seems 
unrealistic. Fortunately, 1.1% of elemental carbon is the 13C isotope, which 
has a spin I = 1/2, so in principle it should be possible to conduct a carbon 
NMR experiment. It is worth noting here, that if much higher abundances of 
13C were naturally  present  in  all  carbon compounds,  proton NMR would 
become much more complicated due to large one-bond coupling of 13C and 
1H.
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The most  important  operational  technique  that  has  led  to  successful  and 
routine  13C NMR spectroscopy  is  the  use  of  high-field  pulse  technology 
coupled  with  broad-band  hetero  nuclear  decoupling of  all  protons.  The 
results of  repeated pulse sequences are accumulated  to provide improved 
signal strength. Also, for reasons that go beyond the present treatment, the 
decoupling irradiation enhances the sensitivity of carbon nuclei bonded to 
hydrogen. When acquired in this manner, the carbon NMR spectrum of a 
compound displays a single sharp signal for each structurally distinct carbon 
atom in a molecule (remember, the proton couplings have been removed). 
The spectrum of camphor, shown on the left below, is typical. Furthermore, 
a comparison with the 1H NMR spectrum on the right illustrates some of the 
advantageous characteristics of carbon NMR. The dispersion of 13C chemical 
shifts is nearly twenty times greater than that for protons, and this together 
with the lack of signal splitting makes it more likely that every structurally 
distinct  carbon  atom  will  produce  a  separate  signal.  The  only  clearly 
identifiable signals in the proton spectrum are those from the methyl groups. 
The remaining protons have resonance  signals  between 1.0 and 2.8 ppm 
from TMS, and they overlap badly thanks to spin-spin splitting. For example 
13C NMR of Camphor is as follows
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3.3.4. 13C NMR OF CAMPHOR
Spectra : 02 
Unlike  proton  NMR  spectroscopy,  the  relative  strength  of  carbon  NMR 
signals  are  not  normally  proportional  to  the number  of  atoms generating 
each one. Because of this, the number of discrete signals and their chemical 
shifts  are  the  most  important  pieces  of  evidence  delivered  by  a  carbon 
spectrum. 
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3.4. MASS SPECTROMETRY
Mass spectrometry is perhaps the most widely applicable of all analytical 
tools provides qualitative and quantitative information about the atomic and 
molecular composition of organic and inorganic materials, biological matter.
• The elemental composition of samples of matter.
• The structure of organic, inorganic and biological molecules.
• Qualitative and quantitative composition of complex mixtures.
• The structure and composition of solid surfaces.
• Isotopic ratios of  atoms in samples.
In this technique, molecules are bombarded with a beam of energetic 
electrons.  The molecules are ionized and broken up into many fragments, 
some of which are positive ions.  Each kind of ion has a particular ratio of 
mass to charge ratio.
Mass spectrum is a record of the masses and the relative abundances of the 
molecular ion and the positively charged fragments formed from it by the 
electron bombardment. The mass spectrum of  a pure compound provides 
several kind of data  which are useful for its identification.
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The mass spectrum is always recorded in the gaseous state. It means that 
complications due to solvents and change of physical state don’t affect the 
nature of mass spectrum.
In mass spectrometry, the quantity of the sample required designated as M+. 
It is positively charged molecule with unpaired electrons.  The set of 
fragment or daughter ions are analysed in such a way that a signal is 
obtained for each volume m/e i.e. is represented.  The intensity of each 
signal represents the relative abundance of the ion producing the signal.  The 
largest peak in the structure is called base peak and its intensity is taken as 
100.  The intensities of other peaks are represented relative to the base peak. 
The fragmentation or cracking pattern for a single substance is uniquely 
characteristic and may be used for qualitative identification purposes.
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4. CHROMATOGRAPHIC TECHNIQUES
Analytical separations were largely carried out by such classical methods as 
precipitation, distillation and extraction.  By now, however analytical 
separations are most commonly carried out by chromatography and 
electrophoresis, particularly with samples that are multicomponent and 
complex. There are various types of chromatographies are there one among 
them is High Performance Liquid Chromatography (HPLC).
4.1. HIGH PERFORMANCE LIQUID CHROAMTOGRAPHY 
(HPLC)
The technique of high performance liquid chromatography was developed in 
the late 1960s and early 1970s from a knowledge of the theoretical 
principles that already had been established for the earlier chromatography 
techniques, in particular for column chromatography and from advances 
made in column packing materials and in the design of chromatographic 
equipment.
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HPLC ranks among the most widely used techniques in pharmaceutical 
analysis.  This is due to several reasons:
 Wide variety of packing materials allows to separate of most chemical 
species.
 Different types of detectors available permit the sensitive detection of 
most chemical types, accuracy and precision with which eluted 
substances may be quantified give analytical data of the highest 
caliber.
 Micro particulate packing materials give excellent separation of 
similar substances.
 Short columns in routine use allow fast separation to take place and 
complete separation of a complex mixtures can be achieved within a 
few minutes.
 Use of automatic samples and injectors enables large number of 
samples to be analysed unattended.
 Combination of HPLC and spectrometric techniques allows the almost 
simultaneously quantitation and identification of solutes as they elute 
from the column.
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 Principal areas of pharmaceutical analysis in which HPLC is routinely 
used are the quality control testing of drugs and medicines for 
compliance with specifications, stability studies, therapeutic 
monitoring, drug metabolism studies and pharmacokinetic studies.
 Useful in providing compound specific assays.
 Separation and control of impurities.
 Column may be reused.
 Applied to wide variety of natural products such as nucleic acids, 
urine, serum, carbohydrates, lipids, amino acids, bile acids, 
pharmaceutical products, pesticides, herbicides, surfactants and 
antioxidants.
 Reverse phase partition HPLC is particularly useful for the separation 
of polar compounds such as drug metabolites, peptides, vitamins, poly 
phenols and steroids.
 In principle HPLC arose from conventional liquid column 
chromatography, following the development of gas liquid 
chromatography and realization that it was a rapid and accurate 
analytical method.
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5.0 Spectral and HPLC studies of the isolated compounds.
The  isolated  compounds  were  subjected  to  various  spectral  studies  and 
HPLC chromatographic studies as follows.
5. 1. Isolated compound S1
 COMPOUND CODE:S1
 PHYSICAL EXAMINATION:
o Colour: Light yellow
o  State : Amorphous powder
 IDENTIFCATION 
a) Chemical  tests :Libbermann-Buchard and Salkowski tests.
b) THIN LAYER CHROMATOGRAPHY:
 Stationary phase  : Silica -gel GF 254
 Mobile phase :Chloroform(97):Diethyl ether 
(2.3): Glacial Acetic acid(0.5)
 Detector : UV 254/365
 Colour : Light green fluorescence
 Rf value : 0.25
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 PHYSICAL CONSTANT
Melting Point: 143°C
 SOLUBILITY:
n- Hexane, Petroleum ether, Chloroform, Benzene and 
Methanol.
 YIELD:   1.8 gms
 UV SPECTRAL DATA: 
λmax 275nm
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 IR  SPECTRAL DATA:
Table: 16                          IR Spectral Details of isolated sterol S1
S. No FREQUENCY cm-1 STRETCHING & DEFORMATION
01 3368 -OH STRETCHING
02 2916-2848 -C-H STRETCHING
03 2360 -C=C- STRETCHING
04 1473-1463 -C-H- DEFORMATION;  -C=C- 
STRETCHING        
05 1261 -O-H DEFORMATION ;–C-O 
STRETCHING
06 1060   Primary OH   STRETCHING
07 803-716    Aromatic Substitution
 NMR SPECTRAL DATA: PMR
Table: 17                          PMR  Spectral Details of isolated sterol S1
S.NO SIGNALS (δ) Values ppm GROUP ASSIGNED
01 7.2 Aryl Protons
02 3.6 Hydroxyl  Protons
03 2.2 Aromatic Carbonyl Protons
04 1.2 Secondary Alkyl Protons
05 5.1 Aromatic Protons
06 -0.018 Off the Scale
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5. 2. Isolated compound S2
• COMPOUND CODE : S2
• PHYSICAL EXAMINATION:
 Colour : Reddish orange.
 State : Sticky mass.
• IDENTIFCATION
a)Test : Libermann-Buchard  and Salkowski tests.
b) THIN LAYER CHROMATOGRAPHY:
 Stationary phase : Silica gel GF 254
 Mobile phase :Chloroform(97):Diethyl ether(2.3):Glacial 
Acetic acid(0.5)
 Detector :UV 254/365
 Colour :Light Rose, Pink, Green and Flourescent 
yellow
 Rf value : 0.25, 0.4, 0.6, 0.88
128
• PHYSICAL CONSTANT
 Melting Point: 138°C
• SOLUBILITY:
 n- Hexane, Petroleum ether,  Chloroform, Benzene and 
Methanol.
• YIELD: 4.2 gms.
• UV SPECTRAL DATA: 
λmax 258 nm
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• IR  SPECTRAL DATA:
Table: 18                          IR Spectral Details of isolated sterol S2
S.No
FREQUENCY 
cm-1
STRETCHING & DEFORMATION
01 3423 -OH STRETCHING
02 2956-2847 C-H STRETCHING
03 1735 C=O STRETCHING in STEROIDAL ESTER
04 1652 C=O STRETCHING
05 1471-1462 -C-H   DEFORMATION
06 1378 -C=O-O :Carboxlyate anion Stretching
07 1178  PhenolicO-H STRETCHING &C-O 
DEFORMATION
08 1060 Primary OH STRETCHING
09 887-719 Aromatic Substitution
5. 3. Isolated compound S3
 COMPOUND CODE: S3
 PHYSICAL EXAMINATION:
o Colour: White
o  State : Waxy
 IDENTIFCATION 
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a) Chemical  tests :Libermann-Buchard and Salkowski tests.
b) THIN LAYER CHROMATOGRAPHY:
 Stationary phase  : Silica -gel GF 254
 Mobile phase : Chloroform(97):Diethyl ether 
(2.3): Glacial Acetic acid(0.5)
 Detector : UV 254/365
 Colour : Flourescent green.
 Rf value : 0.45
 PHYSICAL CONSTANT
Melting Point: 148°C
 SOLUBILITY:
n- Hexane, Petroleum ether, Chloroform, Benzene and Methanol.
 YIELD:   14 mg
 UV SPECTRAL DATA: 
λmax 245nm
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5. 4. Isolated compound S4
 COMPOUND CODE:S4
 PHYSICAL EXAMINATION:
o Colour: White
o  State : Waxy
 IDENTIFCATION 
a) Chemical  tests :Libermann-Buchard and Salkowski tests.
b) THIN LAYER CHROMATOGRAPHY:
 Stationary phase  : Silica -gel GF 254
 Mobile phase :Chloroform(97):Diethyl ether (2.3): Glacial 
Acetic acid(0.5)
 Detector : UV 254/365
 Colour : Flourescent yellow.
 Rf value : 0.62
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 PHYSICAL CONSTANT
Melting Point: 140°C
 SOLUBILITY:
n- Hexane, Petroleum ether, Chloroform, Benzene and 
Methanol.
 YIELD:   16 mg
 UV SPECTRAL DATA: 
λmax 240nm
5. 5. Isolated compound S5
♦ COMPOUND CODE:S5
♦ PHYSICAL EXAMINATION:
o Colour: White
o  State : Waxy
♦ IDENTIFCATION 
a) Chemical  tests
Libermann-Buchard and Salkowski tests.
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b) THIN LAYER CHROMATOGRAPHY:
o Stationary phase  : Silica -gel GF 254
o Mobile phase :Chloroform(97):Diethyl ether (23): Glacial 
Acetic acid(0.5)
o Detector : UV 254/365
o Colour : Light green.
o Rf value : 0.5
♦ PHYSICAL CONSTANT
Melting Point: 165°C
♦ SOLUBILITY:
n- Hexane, Petroleum ether Chloroform & Benzene.
♦ YIELD:   26.2 mg
♦ UV SPECTRAL DATA: 
λmax 241nm
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♦ IR  SPECTRAL DATA:
Table: 19                         IR Spectral Details of isolated sterol S5
S.No FREQUENCY 
cm-1
STRETCHING & DEFORMATION
01 3415 OH STRETCHING
02 2953-2847 C-H STRETCHING   & C=C  aromatic 
STRETCHING
03 1734 C=O STRETCHING in STEROID ESTER
04 1465 -C-C STRETCHING
05 1374 -C-H DEFORMATION
06 1169 -OH DEFORMATION: -C-O STRETCHING 
Secondary alcohol
07 758-723 Aromatic Substitution
5. 6. Isolated compound S6
 COMPOUND CODE:S6
 PHYSICAL EXAMINATION:
o Colour: Pale yellow
o  State : Waxy
 IDENTIFCATION 
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a) Chemical  tests :Libermann-Buchard and Salkowski tests.
b) THIN LAYER CHROMATOGRAPHY:
 Stationary phase  : Silica -gel GF 254
 Mobile phase :Chloroform(97):Diethyl ether (2.3): Glacial 
Acetic acid(0.5)
 Detector : UV 254/365
 Colour : Flourescent Yellow.
 Rf value : 0.81
 PHYSICAL CONSTANT
Melting Point: 185°C
 SOLUBILITY:
n- Hexane, Petroleum ether Chloroform & Benzene.
 YIELD:   07 mg
 UV SPECTRAL DATA: 
λmax 253nm
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5. 7. Isolated compound S7
► COMPOUND CODE:S7
► PHYSICAL EXAMINATION:
o Colour: Yellow
o  State : Waxy
► IDENTIFCATION 
a) Chemical  tests :Libermann-Buchard and Salkowski tests.
b) THIN LAYER CHROMATOGRAPHY:
 Stationary phase  : Silica -gel GF 254
 Mobile phase :Chloroform(97):Diethyl ether (2.3): Glacial 
Acetic acid(0.5)
 Detector : UV 254/365
 Colour : Yellow.
 Rf value : 0.64
► PHYSICAL CONSTANT
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Melting Point: 141°C
► SOLUBILITY:
n- Hexane, Petroleum ether Chloroform & Benzene.
► YIELD:   27 mg
► UV SPECTRAL DATA: 
λmax 254nm
► IR  SPECTRAL DATA:
Table: 20                          IR Spectral Details of isolated sterol S7
S.No FREQUENCY 
cm-1
STRETCHING & DEFORMATION
01 2919-2850 -C-H STRETCHING
02 2362 -C=C- STRETCHING
03 1735 -C=O STRETCHING IN STERIOD ESTER
04 1375 -C-NO2  Carboxlylate anion Stretching
05 1278 -C-O STRETCHING  &–O-H DEFORMATION
06 1094  Secondary OH STRETCHING
07 974-723  Aromatic Substitution
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5. 8. Isolated compound S8
 COMPOUND CODE : S8
 PHYSICAL EXAMINATION:
o Colour : Pale yellow
o State : Amorphous powder.
 IDENTIFCATION
a)Test : Libermann-Buchard  and Salkowski tests.
b) THIN LAYER CHROMATOGRAPHY:
► Stationary phase : Silica gel GF 254
► Mobile phase :Chloroform(97):Diethyl ether(2.3):Glacial 
Acetic acid(0.5)
► Detector :UV 254/365
► Colour :Green.
► Rf value : 0.78
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 PHYSICAL CONSTANT
► Melting Point: 142°C
 SOLUBILITY:
► n- Hexane, Petroleum ether, Chloroform & Benzene.
 YIELD: 473mg.
 UV SPECTRAL DATA: 
λmax 275 nm
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 HPLC Spectra of isolated sterol S8
The isolated sterol S8 were subjected to HPLC  in order to determine the 
impurities in  the isolated compound.
Instrument : Lachrom L –700 Series
Solvent system: Dissolve 15.6g of dibasic sodium phosphate and 12.2 gms 
of monobasic potassium
Flow rate  : 0.6ml/min.
Retention time : 13.45
Percentage purity: 95.56%
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 IR  SPECTRAL DATA:
Table: 21                          IR Spectral Details of isolated sterol S8
S.No FREQUENCY 
cm-1
STRETCHING & DEFORMATION
01 3318 OH STRETCHING
02 2958-2850 -C-H STRETCHING
03 2728-1727 -C=O STRETCHING IN STERIOD ESTER
04 1666 -C-C  MULTIPLE BOND STRETCHING
05 1600-1455 -C-CH3 STRETCHING
06 1378 -C-H DEFORMATION
07 1281 -C-O STRETCHING
08 1218-1128 PHENOLIC OH STRECTHING
09 1037 -C-C STRETCHING
10 836-666 Aromatic Substitution
 NMR SPECTRAL DATA: PMR
Table: 22                      NMR (PMR)  Spectral Details of isolated sterol S8
S.No SIGNALS (δ) Values ppm GROUP ASSIGNED
01 7.7-7.5 Aryl Proton
02 5.4 Aromatic OH Proton
03 4.2 Alkyl OH Proton
04 2.0 CH-C=O Proton
05 1.7-1.6 Non conjugated Proton
06 0.7-1.5 Methyl Proton
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 NMR SPECTRAL DATA: 13C NMR
Table: 23              NMR (13C NMR)  Spectral Details of isolated sterol S8
S.No SIGNALS (δ) Values 
ppm
GROUP ASSIGNED
01 162 Carbonyl group attached to  aromatic 
ring followed by CH2
02 130-125 Aromatic
03 129 Double bond in aromatic
04 072 Solvent peak due to CDCl3
05 032 C-8
06 31.6 C-2
07 028 C-25
08 24.3 C-15
09 24.1 C-22
10 022 C-26 Carbon attached to any group
11 018 C-21 (Methyl group carbon)
12 12 & 19.4 Indicates C18 & C19 in sterol ring
 MASS SPECTRAL DATA
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Table : 24            Mass  Spectral Details of isolated sterol S8
S.No Compound Formula Molecular 
weight
Retention 
time
01 2-Pentadecanone,6,10,14-
trimethyl-
C18H36O 268 3.05
02 Cholestan-3-ol, 2-methylene-, 
(3α, 5α)
C28H48O 400 3.50
03 3,7,11,15-Tetramethyl-2-
hexadecen-1-ol
C20H40O 296 4.94
04 Mono(2-ethylexyl) phthalate C16H22O4 278 9.95
05 α- Amyrin C30H50O 426 24.11
06 Lupeol C30H50O 426 25.35
Based upon UV, IR, NMR and Mass spectral datas the isolated compound S8 
may be 
16-(3,7,11,15- Tetramethyl-2-hexadecen-1-ol)-2-methylene (3α,5α)- 
Cholestan-3-ol.
H2C
CH3CH3
CH3CH3
CH3
HO
CH3CH3CH3CH3
OH
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5. 9. Isolated compound F1
 COMPOUND CODE:F1
 PHYSICAL EXAMINATION:
 Colour: Flourescent Yellow
  State : Amorphous powder
 IDENTIFCATION 
a) Chemical  tests: Shinoda test, Zinc Hydrochloride and Alkaline 
reagent test.
b) THIN LAYER CHROMATOGRAPHY:
 Stationary phase  : Silica -gel GF 254
 Mobile phase :Benzene(9) : Acetone (1)
 Detector : UV 254/365
 Colour : Flourescent green.
 Rf value : 0.79
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 PHYSICAL CONSTANT
Melting Point: 124°C
 SOLUBILITY:
Ethyl acetate and Methanol.
 YIELD:   100 mg
 UV SPECTRAL DATA: 
λmax 365nm
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 IR SPECTRAL DATA:
Table: 25                          IR Spectral Details of isolated Flavanoid F1
S.No FREQUENCY cm-1 STRETCHING & DEFORMATION
01 3406-3322 OH STRETCHING
02 1665-1611 -C=O STRETCHING in lactone ring
03 1562 -CH-CH- STRETCHING 
04 1522 -C=C STRETCHING
05 1451 -CH Deformation
06 1408 -C-O- STRETCHING
07 1382 -OH  Bending &–C-O STRETCHING
08 1262-1197 Phenolic OH STRETCHING
09 722-680 Aromatic Substitution
 NMR SPECTRAL DATA: PMR
Table: 26             NMR (PMR)  Spectral Details of isolated Flavanoid F1
S.No SIGNALS (δ) Values ppm GROUP ASSIGNED
01 7.7 Aryl Proton
02 1.5 Methyl Proton
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13. AIM AND OBJECTIVES OF THE PROPOSED 
WORK
Delonix  regia  (Boj.  ex  Hook.)  Raf.  (Caesalpinaceae)  is  a  well  known 
ornamental tree.  The tree is noted to be as one of the five among the world 
most beautiful ornamental tree.  However the tree was not familiar for its 
medicinal properties. The Delonix regia (Boj. ex Hook.) Raf. said to possess 
very less pharmacological actions and still kept aside just as an ornamental 
plant only.  Various research scholars and scientists tried to explore the plant 
for  its  phytoconstituents  and  pharmacological  properties.   A  thorough 
literature  survey through various  journals,  textbooks and internet  sources 
had been made to study about the current status of the drug.
It is noted that, not much work had been done on the leaves of the tree. So, 
here a clear-cut attempt had been made to explore the phytoconstituents of 
the same through various phytochemical methods. The isolated compounds 
were characterized using various spectroscopical  studies such as UV, IR, 
NMR and Mass spectroscopical methods.
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Free radical have aroused significant interest among scientist in past decade, 
their broad range of effect in biological systems have drawn on the attention 
of many experimental works.  There are extensive evidences to implicate 
free radicals in the development of degenerative diseases such as cancer, 
cardiovascular diseases, rheumatoid arthritis, cataracts, diabetes, alzheimers 
disease and aging. It is suggested that free radical damage to cells leads to 
the pathological changes associated with many diseases and the antioxidant 
mechanism  may  be  important  in  controlling  the  pathogenesis  of  certain 
diseases.  Many synthetic antioxidant components have shown to produce 
toxic  or  mutagenic  effects,  which have  change  the  attention  towards  the 
naturally occurring antioxidants.
The isolated compounds from  Delonix regia  (Boj. ex Hook.) Raf.  leaves 
were subjected to the antioxidant screening models at various concentrations 
both by in vitro and ex vivo methods and tried to found out that whether 
they possess any such properties and if so, which one is better than the other.
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The whole world atmosphere is polluted by means of microbes.  One or the 
other  way they also form as an integral part of the human society itself. 
They are said to causes so many disastrous diseases and infections such as 
Tuberculosis, HIV, fever and the list goes on and on. So in order to check, 
whether our drugs as such possess any antimicrobial  effect,  the alcoholic 
extract of Delonix regia (Boj. ex Hook.) Raf  was screened against microbes 
such as gram positive bacteria, gram negative bacteria and fungus. 
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14.THE RESULTS & DISCUSSION
In the present study from the leaves of  Delonix regia  (Boj. ex Hook.) Raf 
was  subjected  to  phytochemical  screening  along  with  isolation  of 
phytoconstituents.   The  isolated  phytoconstituents  were  characterized  by 
means  of  spectral  studies  and  subjected  to  determine  their  antioxidant 
potential by means of in vitro and ex vivo methods.  The crude extract of the 
plants were tried to determine their anti-microbial potential. 
I. Phytochemical investigation 
The qualitative chemical investigation was carried out to determine the phytoconstituents 
present  in the leaves of the plant.  The tests revealed that the drug may possess 
phytoconstituents such as alkaloids, flavanoids, glycosides, sterols, triterpenoids, tannins, 
carbohydrates and proteins.  Further chromatographical studies were carried out to 
confirm the same.
II. Isolation of Phytoconstituents
Crude isolation of  sterols  were isolated  and confirmed  the  same through 
phytochemical and chromatographical studies.  A systematic approach  had 
been made to  isolate  phytoconstituents  such as  sterols  and flavanoids  by 
means of column chromatography. Eight sterols and  a flavanoid had been 
isolated and confirmed the same. The percentage yield of sterols were 1.8%, 
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4.2%, 0.09%, 0.10%, 1.75%, 0.045%, 1.8%  and 3.15% respectively.  Were 
as the percentage yield of flavanoid was found to be 0.67%.
III. Characterization of isolated phytoconstituents
The isolated phytoconstituents were further subjected various spectral studies such as 
UV, IR, NMR and Mass spectroscopy.  
The isolated phytoconstituents when  subjected to IR spectral studies shows 
the presence of - OH,  -CH, -C=C-, -C=O, γ -lactone stretching and bending, 
aromatic  substitution  within them by exhibiting bands  in  their  respective 
regions.  
Further  the  isolated  compounds  were  observed  for  their   1H  NMR  & 
13CNMR  which revealed the presence aryl, methyl, hydroxyl, carbonyl and 
secondary alkyl proton, which confirms the steroidal ring and lactonic ring.  
To  completely  elucidate  the  structure  of  isolated  sterol  S8 they  were 
subjected  to  fragmentation  by mass  spectroscopical  studies.  At  about  the 
retention  time  3.50 the sample  exhibited a  fragmentation  with molecular 
weight 400 and molecular formula  C28H48O, so the compound S8 may be a 
cholestanol derivative. In the same spectra at about retention time 4.94 there 
was a long chain linear fragment with molecular weight 296 and formula 
C20H40O.  
41
Based  upon  this  the  compound  may  be  named  as  16-(3,7,11,15- 
Tetramethyl-2-hexadecen-1-ol)-2-methylene (3α, 5α)- Cholestan-3-ol .
IV. Physico & Chemcial  evaluation
Delonix regia  (Boj.  ex Hook.)  Raf.  leaves  were subjected  to  ash  values, 
extractive values and elemental analysis.  Total ash of  07.4% and sulphated 
ash of  07.19% ash were observed.  The various extractive values carried out 
shown  the  maximum  percentage  yield  of  47.80%  of  water  soluble 
extractives and minimum percentage yield of 02.938% in n-Hexane soluble 
extractives.  The elemental content such as sodium, potassium and Calcium 
were determined and by means of flame photometer and were found to be 
0.5 mEq, 0.1 mEq and 1.0mEq respectively.
V. Pharmacological evaluation
a. Antimicrobia potential of Delonix regia (Boj. ex Hook.) Raf 
The antibacterial and antifungal activity of  Delonix regia  (Boj. ex Hook.) 
Raf was evaluated by means of using the following Gram positive, Gram 
negative  and  fungus:   Strepto  cocci,  Staphylo  cocci,  Proteus  vulgaris,  
Escherichia coli, Pseudomonas aeuroginosa, Klebsiella aerugenes, Candida  
albicans.  The activities were evaluated at about various concentrations of 
500µg, 750µg, 1000µg  & 2000µg.  Amikacin 5µg and Ketoconazole 10µg 
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were used as the standards for bacteria and fungus.  The extracts had shown 
moderate antibacterial activity when compared with the standard at about a 
dose of 2000µg.  The maximum antibacterial activity was observed against 
Pseudomonas aeuroginosa, which was highly competitive with the standard. 
The extract had shown good anti-fungal activity at the highest concentration 
of 2000µg.
b. Estimation   of Total Phenolics: The percentage of total Phenolics were 
determined to be  19.8845 mg/100gm as gallic acid equivalent which serves 
as the preliminary estimation of antioxidant potential.
c. Antioxidant potential of isolated phytoconstituents 
The isolated sterol and Flavanoid were subjected to antioxidant evaluation 
using reducing power ability, DPPH radical scavenging assay, Nitric oxide 
radical  scavenging  assay  and  Lipid  peroxidation  assay.  The  isolated 
compounds  at  about  5  different  concentrations  of   125µg/ml,  250µg/ml, 
500µg/ml,  750µg/ml  and 1000µg/ml  were  screened  for  their  antioxidant 
properties using ascorbic acid as standard at 01µg/ml, 02µg/ml, 03µg/ml, 
04µg/m1, 5µg/ml for all the models except lipid peroxidation assay.  For 
lipid  peroxidation  assay  ascorbic  acid  was  used  at  25µg/ml,  50µg/ml, 
100µg/ml, 250µg/ml & 500µg/ml concentrations.  
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The isolated compounds were shown good reductive ability with increasing 
concentrations  which  were  comparable  to  the  standard.   The  maximum 
reduction in absorbance was absorbed at 1000µg/ml for both the isolated 
compound and for the standard at 5µg/ml.  
DPPH radical scavenging assay, Nitric oxide radical scavenging assay and 
Lipid  peroxidation  assay  were  carried  out  and  their  IC50 values  were 
determined for the samples and standards. Based on the IC50 values of the 
isolated  compound  it  is  found  that  they  possess  significant  anti-oxidant 
potential as compared to the standard.
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SUMMARY & CONCLUSION
The present study of  Delonix regia (Boj. Ex Hook.) Raf aims at exploring 
the  phytoconstituents  of   it  and  to  characterize  them  along  with  their 
antioxidant  potential.   Further  it  also  tries  to  justify  the  antimicrobial 
properties of the leaves of the tree.  Isolation of sterols and flavanoid was 
done and maximum possibility  of characterization of   isolated sterol was 
carried out. The isolated compound sterol may be found to be as 16 - (3, 7, 
11, 15 – Tetramethyl – 2 – hexadecen – 1 - ol) – 2 - methylene (3α, 5α)- 
Cholestan – 3 - ol.  The anti-microbial study of the leave extract was carried 
out  and  compared  with  the  standard.  The  drug  is  found  to  be  potential 
against  Pseudomonas aeruginosa and  the fungus  Candida albicans.  The 
isolated sterol and flavanoid were evaluated for their antioxidant properties 
using  ascorbic  acid  as  standard.   Both  the  isolated  compounds  found  to 
possess significant  antioxidant potential and as compared to the standard. 
However, the antioxidant potential of flavanoid  was found to be more than 
that of sterol.  These were concluded by means of the lower IC50 values of 
flavanoid than sterol. It can be concluded that the Delonix regia  (Boj. Ex 
Hook.)  Raf,  which is  known better  for  its  ornamental  properties,  can  be 
explored for its pharmacologically active marker phytoconstituents in future. 
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